,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,D,2022-03-14 16:21:25,2022-03-10,BCRX,Sheridan William P,Chief Medical Officer,M - OptEx,$3.22,148302,37954,-134%,"+$477,532",,,,,BCRX
1,D,2022-03-14 16:21:25,2022-03-10,BCRX,Sheridan William P,Chief Medical Officer,S - Sale+OE,$16.88,-161139,37954,-81%,"-$2,719,493",,,,,BCRX
2,,2022-03-09 16:24:11,2022-03-07,BCRX,Babu Yarlagadda S,Chief Discovery Officer,S - Sale,$17.16,-20000,230056,-8%,"-$343,200",,,,,BCRX
3,D,2022-03-03 17:04:41,2022-03-01,BCRX,Jones Michael L,"Exec. Dir, Finance - PAO",M - OptEx,$4.73,2300,11198,+26%,"+$10,879",,,,,BCRX
4,D,2022-03-03 17:04:41,2022-03-01,BCRX,Jones Michael L,"Exec. Dir, Finance - PAO",S - Sale+OE,$17.20,-2300,11198,-17%,"-$39,560",,,,,BCRX
5,,2022-03-02 16:43:55,2022-02-28,BCRX,Levin Alan G,Dir,A - Grant,$16.61,602,2059,+41%,"+$9,999",,,,,BCRX
6,,2022-03-02 16:40:54,2022-02-28,BCRX,Ingram Robert Alexander,Dir,A - Grant,$16.61,1128,80060,+1%,"+$18,736",,,,,BCRX
7,,2022-03-02 16:38:21,2022-02-28,BCRX,Heggie Theresa,Dir,A - Grant,$16.61,602,16225,+4%,"+$9,999",,,,,BCRX
8,,2022-03-02 16:34:42,2022-02-28,BCRX,Aselage Steve,Dir,A - Grant,$16.61,301,33159,+1%,"+$5,000",,,,,BCRX
9,D,2022-02-16 16:25:40,2022-02-15,BCRX,Abercrombie George B,Dir,M - OptEx,$3.32,5000,0,-100%,"+$16,600",,,,,BCRX
10,D,2022-02-16 16:25:40,2022-02-15,BCRX,Abercrombie George B,Dir,S - Sale+OE,$18.50,-5000,0,-100%,"-$92,500",,,,,BCRX
11,D,2022-01-13 16:45:25,2022-01-11,BCRX,Stonehouse Jon P,"Pres, CEO",M - OptEx,$4.73,184000,911602,+25%,"+$870,320",,,,,BCRX
12,D,2022-01-13 16:45:25,2022-01-11,BCRX,Stonehouse Jon P,"Pres, CEO",S - Sale+OE,$15.04,-184000,911602,-17%,"-$2,767,360",,,,,BCRX
13,A,2022-01-13 16:40:59,2021-12-14,BCRX,Doyle Anthony,CFO,A - Grant,$0.00,75000,168719,+80%,+$0,,,,,BCRX
14,A,2022-01-13 16:38:14,2021-12-14,BCRX,Gayer Charles K,Chief Commercial Officer,A - Grant,$0.00,80000,216556,+59%,+$0,,,,,BCRX
15,A,2022-01-13 16:36:00,2021-12-14,BCRX,Barnes Alane P,GC,A - Grant,$0.00,55000,201969,+37%,+$0,,,,,BCRX
16,D,2021-12-16 17:16:28,2021-12-14,BCRX,Jones Michael L,"Exec. Dir, Finance - PAO",A - Grant,$0.00,5850,11198,+109%,+$0,,,,,BCRX
17,D,2021-12-16 17:12:04,2021-12-14,BCRX,Gayer Charles K,Chief Commercial Officer,A - Grant,$0.00,125000,261556,+92%,+$0,,,,,BCRX
18,D,2021-12-16 17:09:07,2021-12-14,BCRX,Babu Yarlagadda S,Chief Discovery Officer,A - Grant,$0.00,35000,250056,+16%,+$0,,,,,BCRX
19,D,2021-12-16 17:06:43,2021-12-14,BCRX,Thackray Helen M.,"Chief R, D Officer",A - Grant,$0.00,44000,144000,+44%,+$0,,,,,BCRX
20,D,2021-12-16 17:03:30,2021-12-14,BCRX,Barnes Alane P,GC,A - Grant,$0.00,75000,221969,+51%,+$0,,,,,BCRX
21,D,2021-12-16 16:59:03,2021-12-14,BCRX,Doyle Anthony,CFO,A - Grant,$0.00,115000,208719,+123%,+$0,,,,,BCRX
22,D,2021-12-16 16:56:46,2021-12-14,BCRX,Sheridan William P,Chief Medical Officer,A - Grant,$0.00,35000,50791,+222%,+$0,,,,,BCRX
23,D,2021-12-16 16:53:41,2021-12-14,BCRX,Stonehouse Jon P,"Pres, CEO",A - Grant,$0.00,123000,911602,+16%,+$0,,,,,BCRX
24,D,2021-12-16 16:53:41,2021-09-01,BCRX,Stonehouse Jon P,"Pres, CEO",G - Gift,$0.00,-20000,911602,+2%,-$0,,,,,BCRX
25,D,2021-12-09 16:38:55,2021-12-07,BCRX,Babu Yarlagadda S,Chief Discovery Officer,M - OptEx,$4.73,62000,215056,+41%,"+$293,260",,,,,BCRX
26,D,2021-12-09 16:38:55,2021-12-07,BCRX,Babu Yarlagadda S,Chief Discovery Officer,S - Sale+OE,$12.20,-30100,215056,-12%,"-$367,220",,,,,BCRX
27,,2021-12-02 16:15:38,2021-11-30,BCRX,Aselage Steve,Dir,A - Grant,$12.06,414,32858,+1%,"+$4,993",,,,,BCRX
28,,2021-12-02 16:13:05,2021-11-30,BCRX,Levin Alan G,Dir,A - Grant,$12.06,829,1457,+132%,"+$9,998",,,,,BCRX
29,,2021-12-02 16:10:58,2021-11-30,BCRX,Heggie Theresa,Dir,A - Grant,$12.06,829,15623,+6%,"+$9,998",,,,,BCRX
30,,2021-12-02 16:08:44,2021-11-30,BCRX,Ingram Robert Alexander,Dir,A - Grant,$12.06,1554,78932,+2%,"+$18,741",,,,,BCRX
31,,2021-11-24 18:35:49,2021-11-24,BCRX,Milano Vincent,Dir,P - Purchase,$12.19,7500,17500,+75%,"+$91,425",,,,,BCRX
32,,2021-11-24 18:35:03,2021-11-23,BCRX,Doyle Anthony,CFO,P - Purchase,$12.48,35258,93719,+60%,"+$440,020",,,,,BCRX
33,D,2021-11-17 16:27:57,2021-11-15,BCRX,Abercrombie George B,Dir,M - OptEx,$3.32,5000,0,-100%,"+$16,600",,,,,BCRX
34,D,2021-11-17 16:27:57,2021-11-15,BCRX,Abercrombie George B,Dir,S - Sale+OE,$12.27,-5000,0,-100%,"-$61,350",,,,,BCRX
35,D,2021-10-19 16:21:49,2021-10-15,BCRX,Hutson Nancy J,Dir,M - OptEx,$3.46,105000,65073,-263%,"+$363,450",,,,,BCRX
36,D,2021-10-19 16:21:49,2021-10-15,BCRX,Hutson Nancy J,Dir,S - Sale+OE,$15.40,-105000,65073,-62%,"-$1,617,000",,,,,BCRX
37,D,2021-09-17 16:31:32,2021-09-15,BCRX,Abercrombie George B,Dir,M - OptEx,$2.63,5000,0,-100%,"+$13,150",,,,,BCRX
38,D,2021-09-17 16:31:32,2021-09-15,BCRX,Abercrombie George B,Dir,S - Sale+OE,$15.06,-5000,0,-100%,"-$75,300",,,,,BCRX
39,D,2021-09-15 16:26:43,2021-09-13,BCRX,Lee Kenneth B Jr,Dir,M - OptEx,$3.22,15000,24252,+162%,"+$48,300",,,,,BCRX
40,D,2021-09-15 16:26:43,2021-09-13,BCRX,Lee Kenneth B Jr,Dir,S - Sale+OE,$15.35,-6000,24252,-20%,"-$92,100",,,,,BCRX
41,D,2021-09-14 16:14:23,2021-09-10,BCRX,Abercrombie George B,Dir,M - OptEx,$2.86,71000,0,-100%,"+$202,710",,,,,BCRX
42,D,2021-09-14 16:14:23,2021-09-10,BCRX,Abercrombie George B,Dir,S - Sale+OE,$15.09,-74000,0,-100%,"-$1,116,660",,,,,BCRX
43,,2021-09-02 16:36:23,2021-08-31,BCRX,Levin Alan G,Dir,A - Grant,$15.92,628,628,New,"+$9,998",,,,,BCRX
44,,2021-09-02 16:33:48,2021-08-31,BCRX,Ingram Robert Alexander,Dir,A - Grant,$15.92,1177,77378,+2%,"+$18,738",,,,,BCRX
45,,2021-09-02 16:30:55,2021-08-31,BCRX,Heggie Theresa,Dir,A - Grant,$15.92,628,14794,+4%,"+$9,998",,,,,BCRX
46,,2021-09-02 16:28:26,2021-08-31,BCRX,Aselage Steve,Dir,A - Grant,$15.92,314,32444,+1%,"+$4,999",,,,,BCRX
47,D,2021-07-19 16:39:54,2021-07-15,BCRX,Abercrombie George B,Dir,M - OptEx,$2.63,5000,3000,-250%,"+$13,150",,,,,BCRX
48,D,2021-07-19 16:39:54,2021-07-15,BCRX,Abercrombie George B,Dir,S - Sale+OE,$15.69,-5000,3000,-63%,"-$78,450",,,,,BCRX
49,D,2021-06-14 16:29:33,2021-06-10,BCRX,Hutson Nancy J,Dir,M - OptEx,$3.15,23333,65073,+56%,"+$73,549",,,,,BCRX
50,D,2021-06-14 16:29:33,2021-06-10,BCRX,Hutson Nancy J,Dir,S - Sale+OE,$16.86,-23333,65073,-26%,"-$393,394",,,,,BCRX
51,DM,2021-06-01 16:33:12,2021-05-27,BCRX,Sheridan William P,Chief Medical Officer,M - OptEx,$5.33,163573,14475,-110%,"+$871,940",,,,,BCRX
52,DM,2021-06-01 16:33:12,2021-05-27,BCRX,Sheridan William P,Chief Medical Officer,S - Sale+OE,$15.01,-163573,14475,-92%,"-$2,455,431",,,,,BCRX
53,,2021-06-01 16:27:39,2021-05-28,BCRX,Ingram Robert Alexander,Dir,A - Grant,$15.77,1188,76201,+2%,"+$18,735",,,,,BCRX
54,,2021-06-01 16:24:09,2021-05-28,BCRX,Hutson Nancy J,Dir,A - Grant,$15.77,317,65073,0%,"+$4,999",,,,,BCRX
55,,2021-06-01 16:18:07,2021-05-28,BCRX,Heggie Theresa,Dir,A - Grant,$15.77,317,14166,+2%,"+$4,999",,,,,BCRX
56,,2021-06-01 16:16:05,2021-05-28,BCRX,Aselage Steve,Dir,A - Grant,$15.77,634,32130,+2%,"+$9,998",,,,,BCRX
57,D,2021-05-26 16:12:11,2021-05-24,BCRX,Abercrombie George B,Dir,M - OptEx,$2.63,6667,3000,-182%,"+$17,534",,,,,BCRX
58,D,2021-05-26 16:12:11,2021-05-24,BCRX,Abercrombie George B,Dir,S - Sale+OE,$13.90,-6667,3000,-69%,"-$92,671",,,,,BCRX
59,DM,2021-05-13 16:43:13,2021-05-11,BCRX,Barnes Alane P,GC,M - OptEx,$4.29,138632,146127,>999%,"+$595,022",,,,,BCRX
60,D,2021-05-13 16:43:13,2021-05-11,BCRX,Barnes Alane P,GC,S - Sale+OE,$12.04,-102780,146127,-41%,"-$1,237,471",,,,,BCRX
61,,2021-05-12 17:02:04,2021-05-10,BCRX,Abercrombie George B,Dir,S - Sale,$12.70,-7000,3000,-70%,"-$88,900",,,,,BCRX
62,D,2021-04-02 17:26:34,2021-03-31,BCRX,Thackray Helen M.,"Chief R, D Officer",A - Grant,$0.00,100000,100000,New,+$0,,,,,BCRX
63,D,2021-03-22 16:19:34,2021-03-18,BCRX,Jones Michael L,"Exec. Dir, Finance - PAO",M - OptEx,$3.51,4500,5348,+531%,"+$15,795",,,,,BCRX
64,,2021-03-02 16:55:44,2021-02-26,BCRX,Ingram Robert Alexander,Dir,A - Grant,$10.78,1739,75013,+2%,"+$18,746",,,,,BCRX
65,,2021-03-02 16:53:50,2021-02-26,BCRX,Hutson Nancy J,Dir,A - Grant,$10.78,463,64756,+1%,"+$4,991",,,,,BCRX
66,,2021-03-02 16:50:53,2021-02-26,BCRX,Heggie Theresa,Dir,A - Grant,$10.78,463,13849,+3%,"+$4,991",,,,,BCRX
67,,2021-03-02 16:47:59,2021-02-26,BCRX,Aselage Steve,Dir,A - Grant,$10.78,927,31496,+3%,"+$9,993",,,,,BCRX
68,D,2021-02-24 16:34:51,2021-02-22,BCRX,Sheridan William P,SVP - CMO,M - OptEx,$4.15,41250,11475,-139%,"+$171,188",,,,,BCRX
69,D,2021-02-24 16:34:51,2021-02-22,BCRX,Sheridan William P,SVP - CMO,S - Sale+OE,$11.57,-41250,11475,-78%,"-$477,263",,,,,BCRX
70,D,2021-02-23 16:25:02,2021-02-19,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$11.53,-22431,183156,-11%,"-$258,629",,,,,BCRX
71,D,2021-02-23 16:25:02,2021-02-19,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,M - OptEx,$4.15,50000,183156,+38%,"+$207,500",,,,,BCRX
72,D,2020-12-17 16:20:55,2020-12-15,BCRX,Stonehouse Jon P,"Pres, CEO",M - OptEx,$4.15,134278,784086,+21%,"+$557,254",,,,,BCRX
73,D,2020-12-17 16:20:55,2020-12-15,BCRX,Stonehouse Jon P,"Pres, CEO",S - Sale+OE,$8.32,-134278,784086,-15%,"-$1,117,193",,,,,BCRX
74,D,2020-12-15 17:35:26,2020-12-11,BCRX,Barnes Alane P,"SVP, GC",M - OptEx,$4.15,13741,108061,+15%,"+$57,025",,,,,BCRX
75,D,2020-12-15 17:35:26,2020-12-11,BCRX,Barnes Alane P,"SVP, GC",S - Sale+OE,$7.96,-13741,108061,-11%,"-$109,378",,,,,BCRX
76,D,2020-12-08 16:12:33,2020-12-04,BCRX,Barnes Alane P,"SVP, GC",M - OptEx,$4.15,13741,108061,+15%,"+$57,025",,,,,BCRX
77,D,2020-12-08 16:12:33,2020-12-04,BCRX,Barnes Alane P,"SVP, GC",S - Sale+OE,$6.23,-13741,108061,-11%,"-$85,606",,,,,BCRX
78,,2020-12-02 16:21:51,2020-11-30,BCRX,Heggie Theresa,Dir,A - Grant,$5.11,978,13386,+8%,"+$4,998",,,,,BCRX
79,,2020-12-02 16:19:44,2020-11-30,BCRX,Aselage Steve,Dir,A - Grant,$5.11,1956,30569,+7%,"+$9,995",,,,,BCRX
80,,2020-12-02 16:16:41,2020-11-30,BCRX,Hutson Nancy J,Dir,A - Grant,$5.11,978,64293,+2%,"+$4,998",,,,,BCRX
81,,2020-12-02 16:14:28,2020-11-30,BCRX,Ingram Robert Alexander,Dir,A - Grant,$5.11,3669,73274,+5%,"+$18,749",,,,,BCRX
82,,2020-09-02 16:44:11,2020-08-31,BCRX,Hutson Nancy J,Dir,A - Grant,$4.15,1204,63315,+2%,"+$4,997",,,,,BCRX
83,,2020-09-02 16:39:52,2020-08-31,BCRX,Heggie Theresa,Dir,A - Grant,$4.15,1204,12408,+11%,"+$4,997",,,,,BCRX
84,,2020-09-02 16:36:57,2020-08-31,BCRX,Aselage Steve,Dir,A - Grant,$4.15,2409,28613,+9%,"+$9,997",,,,,BCRX
85,,2020-09-02 16:33:26,2020-08-31,BCRX,Ingram Robert Alexander,Dir,A - Grant,$4.15,4518,69605,+7%,"+$18,750",,,,,BCRX
86,,2020-08-12 16:31:02,2020-08-11,BCRX,Doyle Anthony,CFO,P - Purchase,$4.08,54000,54000,New,"+$220,320",,,,,BCRX
87,,2020-06-03 16:24:32,2020-06-01,BCRX,Aselage Steve,Dir,A - Grant,$4.50,1112,26204,+4%,"+$4,998",,,,,BCRX
88,,2020-06-03 16:22:33,2020-06-01,BCRX,Heggie Theresa,Dir,A - Grant,$4.50,1112,11204,+11%,"+$4,998",,,,,BCRX
89,,2020-06-03 16:20:07,2020-06-01,BCRX,Hutson Nancy J,Dir,A - Grant,$4.50,2224,62111,+4%,"+$9,997",,,,,BCRX
90,,2020-06-03 16:16:27,2020-06-01,BCRX,Ingram Robert Alexander,Dir,A - Grant,$4.50,4171,65087,+7%,"+$18,749",,,,,BCRX
91,,2020-03-03 16:59:16,2020-03-01,BCRX,Aselage Steve,Dir,A - Grant,$3.00,1666,25092,+7%,"+$4,998",,,,,BCRX
92,,2020-03-03 16:56:48,2020-03-01,BCRX,Heggie Theresa,Dir,A - Grant,$3.00,1666,10092,+20%,"+$4,998",,,,,BCRX
93,,2020-03-03 16:50:11,2020-03-01,BCRX,Hutson Nancy J,Dir,A - Grant,$3.00,3333,59887,+6%,"+$9,999",,,,,BCRX
94,,2020-03-03 16:47:35,2020-03-01,BCRX,Ingram Robert Alexander,Dir,A - Grant,$3.00,6250,60916,+11%,"+$18,750",,,,,BCRX
95,,2019-12-03 17:17:19,2019-12-01,BCRX,Heggie Theresa,Dir,A - Grant,$2.85,1754,8426,+26%,"+$4,999",,,,,BCRX
96,,2019-12-03 17:14:26,2019-12-01,BCRX,Aselage Steve,Dir,A - Grant,$2.85,1754,23426,+8%,"+$4,999",,,,,BCRX
97,,2019-12-03 17:12:07,2019-12-01,BCRX,Hutson Nancy J,Dir,A - Grant,$2.85,3508,56554,+7%,"+$9,998",,,,,BCRX
98,,2019-12-03 17:09:23,2019-12-01,BCRX,Ingram Robert Alexander,Dir,A - Grant,$2.85,6578,54666,+14%,"+$18,747",,,,,BCRX
99,,2019-11-18 16:17:57,2019-11-18,BCRX,Stonehouse Jon P,"Pres, CEO",P - Purchase,$1.45,50000,778086,+7%,"+$72,500",,,,,BCRX
100,,2019-11-18 16:16:18,2019-11-18,BCRX,Sniecinski Megan,Chief Business Officer,P - Purchase,$1.45,45000,45000,New,"+$65,250",,,,,BCRX
101,,2019-11-18 16:14:09,2019-11-18,BCRX,Lee Kenneth B Jr,Dir,P - Purchase,$1.45,5000,15252,+49%,"+$7,250",,,,,BCRX
102,,2019-11-18 16:12:23,2019-11-18,BCRX,Ingram Robert Alexander,Dir,P - Purchase,$1.45,20000,48088,+71%,"+$29,000",,,,,BCRX
103,,2019-11-18 16:10:07,2019-11-18,BCRX,Hutson Nancy J,Dir,P - Purchase,$1.45,10000,53046,+23%,"+$14,500",,,,,BCRX
104,,2019-11-18 16:08:15,2019-11-18,BCRX,Heggie Theresa,Dir,P - Purchase,$1.45,5000,6672,+299%,"+$7,250",,,,,BCRX
105,,2019-11-18 16:05:19,2019-11-18,BCRX,Barnes Alane P,"SVP, GC",P - Purchase,$1.45,20000,102061,+24%,"+$29,000",,,,,BCRX
106,,2019-11-18 16:03:26,2019-11-18,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,P - Purchase,$1.45,25000,155587,+19%,"+$36,250",,,,,BCRX
107,,2019-11-18 16:01:05,2019-11-18,BCRX,Aselage Steve,Dir,P - Purchase,$1.45,15000,21672,+225%,"+$21,750",,,,,BCRX
108,,2019-09-04 16:16:46,2019-09-01,BCRX,Heggie Theresa,Dir,A - Grant,$2.99,1672,1672,New,"+$4,999",,,,,BCRX
109,,2019-09-04 16:14:44,2019-09-01,BCRX,Aselage Steve,Dir,A - Grant,$2.99,1672,6672,+33%,"+$4,999",,,,,BCRX
110,,2019-09-04 16:12:10,2019-09-01,BCRX,Hutson Nancy J,Dir,A - Grant,$2.99,3344,43046,+8%,"+$9,999",,,,,BCRX
111,,2019-09-04 16:08:04,2019-09-01,BCRX,Ingram Robert Alexander,Dir,A - Grant,$2.99,6270,28088,+29%,"+$18,747",,,,,BCRX
112,,2019-05-24 16:20:00,2019-05-22,BCRX,Aselage Steve,Dir,P - Purchase,$3.57,3000,5000,+150%,"+$10,710",,,,,BCRX
113,D,2019-05-20 16:21:51,2019-05-16,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$1.42,4750,125176,+4%,"+$6,745",,,,,BCRX
114,DM,2019-05-20 16:21:51,2019-05-16,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$7.65,-9750,125176,-7%,"-$74,595",,,,,BCRX
115,DM,2019-05-16 16:29:17,2019-05-14,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$1.42,9250,130176,+8%,"+$13,135",,,,,BCRX
116,DM,2019-05-16 16:29:17,2019-05-14,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$7.81,-11750,130176,-8%,"-$91,710",,,,,BCRX
117,DM,2019-05-13 16:57:28,2019-05-09,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$5.51,19500,132676,+17%,"+$107,445",,,,,BCRX
118,DM,2019-05-13 16:57:28,2019-05-09,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$7.70,-19500,132676,-13%,"-$150,053",,,,,BCRX
119,DM,2019-05-06 16:51:03,2019-05-02,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$5.51,16750,132676,+14%,"+$92,293",,,,,BCRX
120,DM,2019-05-06 16:51:03,2019-05-02,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$7.54,-16750,132676,-11%,"-$126,325",,,,,BCRX
121,D,2019-04-08 14:30:00,2019-04-04,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$5.51,7500,132676,+6%,"+$41,325",,,,,BCRX
122,D,2019-04-08 14:30:00,2019-04-04,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$8.81,-7500,132676,-5%,"-$66,075",,,,,BCRX
123,,2019-03-14 16:18:39,2019-03-12,BCRX,Aselage Steve,Dir,P - Purchase,$8.30,2000,2000,New,"+$16,600",,,,,BCRX
124,D,2019-02-04 16:13:08,2019-01-31,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$8.68,-9387,130587,-7%,"-$81,479",,,,,BCRX
125,D,2019-02-04 16:13:08,2019-01-31,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,M - OptEx,$1.20,31874,130587,+32%,"+$38,249",,,,,BCRX
126,D,2019-01-30 16:10:45,2019-01-28,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$5.45,5000,128426,+4%,"+$27,250",,,,,BCRX
127,D,2019-01-30 16:10:45,2019-01-28,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$9.85,-5000,128426,-4%,"-$49,250",,,,,BCRX
128,DM,2019-01-29 16:21:51,2019-01-25,BCRX,Powell Lynne,SVP - CCO,M - OptEx,$3.22,12000,0,-100%,"+$38,640",,,,,BCRX
129,DM,2019-01-29 16:21:51,2019-01-25,BCRX,Powell Lynne,SVP - CCO,S - Sale+OE,$9.75,-12000,0,-100%,"-$116,940",,,,,BCRX
130,D,2019-01-23 16:12:20,2019-01-18,BCRX,Powell Lynne,SVP - CCO,M - OptEx,$3.22,2000,0,-100%,"+$6,440",,,,,BCRX
131,D,2019-01-23 16:12:20,2019-01-18,BCRX,Powell Lynne,SVP - CCO,S - Sale+OE,$9.40,-2000,0,-100%,"-$18,800",,,,,BCRX
132,D,2019-01-18 16:03:16,2019-01-16,BCRX,Powell Lynne,SVP - CCO,M - OptEx,$3.22,3046,0,-100%,"+$9,808",,,,,BCRX
133,D,2019-01-18 16:03:16,2019-01-16,BCRX,Powell Lynne,SVP - CCO,S - Sale+OE,$9.27,-3046,0,-100%,"-$28,236",,,,,BCRX
134,D,2019-01-16 16:24:32,2019-01-14,BCRX,Powell Lynne,SVP - CCO,M - OptEx,$3.22,954,0,-100%,"+$3,072",,,,,BCRX
135,D,2019-01-16 16:24:32,2019-01-14,BCRX,Powell Lynne,SVP - CCO,S - Sale+OE,$9.20,-954,0,-100%,"-$8,777",,,,,BCRX
136,,2019-01-03 16:38:54,2019-01-01,BCRX,Barnes Alane P,"SVP, GC",F - Tax,$8.07,-423,77530,-1%,"-$3,414",,,,,BCRX
137,,2019-01-03 16:36:46,2019-01-01,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$8.07,-771,108100,-1%,"-$6,222",,,,,BCRX
138,,2019-01-03 16:33:52,2019-01-01,BCRX,Sheridan William P,SVP - CMO,F - Tax,$8.07,-1087,1638,-40%,"-$8,772",,,,,BCRX
139,,2019-01-03 16:30:09,2019-01-01,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$8.07,-785,132676,-1%,"-$6,335",,,,,BCRX
140,,2019-01-03 16:27:38,2019-01-01,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$8.07,-3568,724106,0%,"-$28,794",,,,,BCRX
141,,2018-12-20 16:37:19,2018-12-18,BCRX,Sheridan William P,SVP - CMO,S - Sale,$7.58,-20488,2725,-88%,"-$155,299",,,,,BCRX
142,D,2018-12-12 16:13:43,2018-12-10,BCRX,Powell Lynne,SVP - CCO,M - OptEx,$3.22,4000,0,-100%,"+$12,880",,,,,BCRX
143,D,2018-12-12 16:13:43,2018-12-10,BCRX,Powell Lynne,SVP - CCO,S - Sale+OE,$9.06,-4000,0,-100%,"-$36,240",,,,,BCRX
144,D,2018-12-06 16:34:07,2018-12-03,BCRX,Stonehouse Jon P,"Pres, CEO",M - OptEx,$1.20,80000,727674,+12%,"+$96,000",,,,,BCRX
145,D,2018-12-06 16:34:07,2018-12-03,BCRX,Stonehouse Jon P,"Pres, CEO",S - Sale+OE,$9.12,-80000,727674,-10%,"-$729,600",,,,,BCRX
146,,2018-12-06 16:30:51,2018-12-04,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale,$9.45,-3922,133461,-3%,"-$37,063",,,,,BCRX
147,D,2018-12-04 16:11:14,2018-11-30,BCRX,Barnes Alane P,"SVP, GC",M - OptEx,$1.42,25000,77953,+47%,"+$35,500",,,,,BCRX
148,D,2018-12-04 16:11:14,2018-11-30,BCRX,Barnes Alane P,"SVP, GC",S - Sale+OE,$9.07,-44290,77953,-36%,"-$401,710",,,,,BCRX
149,D,2018-11-30 16:02:47,2018-11-28,BCRX,Erck Stanley C,Dir,M - OptEx,$1.49,8333,48333,+21%,"+$12,416",,,,,BCRX
150,DM,2018-11-21 16:51:01,2018-11-19,BCRX,Powell Lynne,SVP - CCO,M - OptEx,$3.22,9320,2455,-136%,"+$30,010",,,,,BCRX
151,DM,2018-11-21 16:51:01,2018-11-19,BCRX,Powell Lynne,SVP - CCO,S - Sale+OE,$8.55,-15470,2455,-86%,"-$132,315",,,,,BCRX
152,DM,2018-11-21 16:48:15,2018-11-19,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.45,11198,137383,+9%,"+$38,688",,,,,BCRX
153,DM,2018-11-21 16:48:15,2018-11-19,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$8.67,-11198,137383,-8%,"-$97,117",,,,,BCRX
154,DM,2018-11-09 16:14:46,2018-11-07,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.31,14087,137383,+11%,"+$46,649",,,,,BCRX
155,DM,2018-11-09 16:14:46,2018-11-07,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$8.12,-14087,137383,-9%,"-$114,387",,,,,BCRX
156,DM,2018-11-09 16:11:55,2018-11-07,BCRX,Powell Lynne,SVP - CCO,M - OptEx,$3.22,5580,8605,+184%,"+$17,968",,,,,BCRX
157,DM,2018-11-09 16:11:55,2018-11-07,BCRX,Powell Lynne,SVP - CCO,S - Sale+OE,$8.14,-5580,8605,-39%,"-$45,432",,,,,BCRX
158,D,2018-11-07 16:05:54,2018-11-05,BCRX,Powell Lynne,SVP - CCO,M - OptEx,$3.22,100,8605,+1%,+$322,,,,,BCRX
159,D,2018-11-07 16:05:54,2018-11-05,BCRX,Powell Lynne,SVP - CCO,S - Sale+OE,$8.00,-100,8605,-1%,-$800,,,,,BCRX
160,D,2018-11-07 16:03:32,2018-11-05,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.22,215,137383,0%,+$692,,,,,BCRX
161,D,2018-11-07 16:03:32,2018-11-05,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$8.00,-215,137383,0%,"-$1,720",,,,,BCRX
162,D,2018-11-06 16:07:26,2018-11-02,BCRX,Powell Lynne,SVP - CCO,M - OptEx,$3.22,1000,8605,+13%,"+$3,220",,,,,BCRX
163,D,2018-11-06 16:07:26,2018-11-02,BCRX,Powell Lynne,SVP - CCO,S - Sale+OE,$8.00,-1000,8605,-10%,"-$8,000",,,,,BCRX
164,D,2018-11-06 16:04:41,2018-11-02,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.40,10856,137383,+9%,"+$36,916",,,,,BCRX
165,D,2018-11-06 16:04:41,2018-11-02,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$7.84,-10856,137383,-7%,"-$85,090",,,,,BCRX
166,,2018-11-05 13:17:36,2018-11-01,BCRX,Powell Lynne,SVP - CCO,S - Sale,$7.51,-1544,8605,-15%,"-$11,595",,,,,BCRX
167,D,2018-10-23 13:34:24,2018-10-19,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.78,3150,137383,+2%,"+$11,907",,,,,BCRX
168,D,2018-10-23 13:34:24,2018-10-19,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$7.45,-3150,137383,-2%,"-$23,468",,,,,BCRX
169,,2018-10-23 13:31:07,2018-10-19,BCRX,Powell Lynne,SVP - CCO,S - Sale,$7.50,-100,10149,-1%,-$750,,,,,BCRX
170,DM,2018-10-04 13:09:15,2018-10-02,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.41,9850,137383,+8%,"+$33,593",,,,,BCRX
171,DM,2018-10-04 13:09:15,2018-10-02,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$7.24,-9850,137383,-7%,"-$71,358",,,,,BCRX
172,D,2018-08-13 10:07:38,2018-08-09,BCRX,Sheridan William P,SVP - CMO,M - OptEx,$1.42,62500,23213,-159%,"+$88,750",,,,,BCRX
173,D,2018-08-13 10:07:38,2018-08-09,BCRX,Sheridan William P,SVP - CMO,S - Sale+OE,$7.03,-62500,23213,-73%,"-$439,375",,,,,BCRX
174,D,2018-06-05 15:07:59,2018-06-01,BCRX,Sheridan William P,SVP - CMO,M - OptEx,$2.58,42112,21058,-200%,"+$108,649",,,,,BCRX
175,D,2018-06-05 15:07:59,2018-06-01,BCRX,Sheridan William P,SVP - CMO,S - Sale+OE,$6.30,-42112,21058,-67%,"-$265,306",,,,,BCRX
176,,2018-06-04 14:54:02,2018-06-01,BCRX,Ingram Robert Alexander,Dir,A - Grant,$6.43,2916,21818,+15%,"+$18,750",,,,,BCRX
177,,2018-06-04 14:48:46,2018-06-01,BCRX,Hutson Nancy J,Dir,A - Grant,$6.43,1555,39702,+4%,"+$9,999",,,,,BCRX
178,D,2018-05-21 09:31:40,2018-05-17,BCRX,Stonehouse Jon P,"Pres, CEO",M - OptEx,$1.42,70427,725519,+11%,"+$100,006",,,,,BCRX
179,D,2018-05-17 09:25:42,2018-05-15,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$5.91,-3004,95264,-3%,"-$17,754",,,,,BCRX
180,D,2018-05-17 09:25:42,2018-05-15,BCRX,Barnes Alane P,"VP, GC, Corp Sec",M - OptEx,$1.42,12500,95264,+15%,"+$17,750",,,,,BCRX
181,D,2018-03-08 15:48:10,2018-03-06,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$5.18,-21125,108871,-16%,"-$109,428",,,,,BCRX
182,D,2018-03-08 15:48:10,2018-03-06,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,M - OptEx,$3.26,30000,108871,+38%,"+$97,800",,,,,BCRX
183,D,2018-03-02 14:23:25,2018-02-28,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$4.97,-43224,655092,-6%,"-$214,823",,,,,BCRX
184,D,2018-03-02 14:23:25,2018-02-28,BCRX,Stonehouse Jon P,"Pres, CEO",M - OptEx,$3.26,56949,655092,+10%,"+$185,654",,,,,BCRX
185,D,2018-03-02 14:21:05,2018-02-28,BCRX,Barnes Alane P,"VP, GC, Corp Sec",M - OptEx,$3.26,6709,85768,+8%,"+$21,871",,,,,BCRX
186,,2018-03-02 14:14:20,2018-03-01,BCRX,Ingram Robert Alexander,Dir,A - Grant,$4.97,3772,18902,+25%,"+$18,747",,,,,BCRX
187,,2018-03-02 14:11:48,2018-03-01,BCRX,Hutson Nancy J,Dir,A - Grant,$4.97,2012,38147,+6%,"+$10,000",,,,,BCRX
188,,2018-01-23 09:12:47,2018-01-20,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$5.59,-1961,77129,-2%,"-$10,962",,,,,BCRX
189,,2018-01-23 09:10:34,2018-01-20,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$5.59,-3872,99996,-4%,"-$21,644",,,,,BCRX
190,,2018-01-23 09:08:02,2018-01-20,BCRX,Sheridan William P,SVP - CMO,F - Tax,$5.59,-4628,18058,-20%,"-$25,871",,,,,BCRX
191,,2018-01-23 09:06:12,2018-01-20,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$5.59,-3979,137383,-3%,"-$22,243",,,,,BCRX
192,,2018-01-23 09:03:38,2018-01-20,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$5.59,-9584,638367,-1%,"-$53,575",,,,,BCRX
193,,2018-01-03 09:13:25,2018-01-01,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$4.91,-459,79090,-1%,"-$2,254",,,,,BCRX
194,,2018-01-03 09:11:29,2018-01-01,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$4.91,-838,103868,-1%,"-$4,115",,,,,BCRX
195,,2018-01-03 09:04:37,2018-01-01,BCRX,Sheridan William P,SVP - CMO,F - Tax,$4.91,-1169,22686,-5%,"-$5,740",,,,,BCRX
196,,2018-01-03 09:02:02,2018-01-01,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$4.91,-852,141362,-1%,"-$4,183",,,,,BCRX
197,,2018-01-03 08:59:35,2018-01-01,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$4.91,-2716,647951,0%,"-$13,336",,,,,BCRX
198,,2017-12-04 15:53:36,2017-12-01,BCRX,Ingram Robert Alexander,Dir,A - Grant,$5.08,3690,15130,+32%,"+$18,745",,,,,BCRX
199,,2017-12-04 15:50:46,2017-12-01,BCRX,Hutson Nancy J,Dir,A - Grant,$5.08,1968,36135,+6%,"+$9,997",,,,,BCRX
200,,2017-11-15 16:09:52,2017-11-13,BCRX,Sheridan William P,SVP - CMO,S - Sale,$4.72,-64310,23855,-73%,"-$303,543",,,,,BCRX
201,D,2017-09-20 10:07:37,2017-09-18,BCRX,Cohen Fred E,Dir,M - OptEx,$4.27,54250,119410,+83%,"+$231,648",,,,,BCRX
202,D,2017-09-20 10:07:37,2017-09-18,BCRX,Cohen Fred E,Dir,S - Sale+OE,$5.42,-54250,119410,-31%,"-$294,035",,,,,BCRX
203,,2017-09-05 11:29:42,2017-09-01,BCRX,Ingram Robert Alexander,Dir,A - Grant,$5.10,3676,11440,+47%,"+$18,748",,,,,BCRX
204,,2017-09-05 11:27:28,2017-09-01,BCRX,Hutson Nancy J,Dir,A - Grant,$5.10,1960,34167,+6%,"+$9,996",,,,,BCRX
205,,2017-06-02 16:04:23,2017-06-01,BCRX,Ingram Robert Alexander,Dir,A - Grant,$5.15,1941,7764,+33%,"+$9,996",,,,,BCRX
206,,2017-06-02 16:01:58,2017-06-01,BCRX,Hutson Nancy J,Dir,A - Grant,$5.15,1941,32207,+6%,"+$9,996",,,,,BCRX
207,,2017-06-02 15:59:51,2017-06-01,BCRX,Cohen Fred E,Dir,A - Grant,$5.15,1941,119410,+2%,"+$9,996",,,,,BCRX
208,D,2017-05-24 16:33:19,2017-05-22,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$5.24,-6996,142214,-5%,"-$36,659",,,,,BCRX
209,D,2017-05-24 16:33:19,2017-05-22,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$4.73,7750,142214,+6%,"+$36,658",,,,,BCRX
210,D,2017-03-22 10:40:59,2017-03-20,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.78,3250,141460,+2%,"+$12,285",3.0,4.0,-20.0,,BCRX
211,D,2017-03-22 10:40:59,2017-03-20,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$9.20,-3250,141460,-2%,"-$29,900",3.0,4.0,-20.0,,BCRX
212,D,2017-03-20 15:01:53,2017-03-16,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$8.80,-12308,141460,-8%,"-$108,310",4.0,-1.0,-25.0,,BCRX
213,D,2017-03-20 15:01:53,2017-03-16,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$2.97,36455,141460,+35%,"+$108,300",4.0,-1.0,-25.0,,BCRX
214,D,2017-03-14 13:47:43,2017-03-10,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.78,3250,117313,+3%,"+$12,285",-3.0,7.0,-16.0,,BCRX
215,D,2017-03-14 13:47:43,2017-03-10,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$9.06,-3250,117313,-3%,"-$29,445",-3.0,7.0,-16.0,,BCRX
216,D,2017-03-10 16:19:09,2017-03-08,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.78,6500,117313,+6%,"+$24,570",-3.0,-1.0,-19.0,,BCRX
217,D,2017-03-10 16:19:09,2017-03-08,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$8.43,-6500,117313,-5%,"-$54,763",-3.0,-1.0,-19.0,,BCRX
218,D,2017-03-08 08:05:54,2017-03-06,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.78,3250,117313,+3%,"+$12,285",8.0,8.0,-3.0,,BCRX
219,D,2017-03-08 08:05:54,2017-03-06,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$7.90,-3250,117313,-3%,"-$25,675",8.0,8.0,-3.0,,BCRX
220,,2017-03-02 15:07:54,2017-03-02,BCRX,Ingram Robert Alexander,Dir,A - Grant,$6.24,1602,5823,+38%,"+$9,996",8.0,23.0,21.0,,BCRX
221,,2017-03-02 15:05:37,2017-03-01,BCRX,Hutson Nancy J,Dir,A - Grant,$6.24,1602,30266,+6%,"+$9,996",8.0,23.0,21.0,,BCRX
222,,2017-03-02 15:03:39,2017-03-01,BCRX,Cohen Fred E,Dir,A - Grant,$6.24,1602,117469,+1%,"+$9,996",8.0,23.0,21.0,,BCRX
223,,2017-01-24 09:28:01,2017-01-20,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$5.95,-2599,75497,-3%,"-$15,464",6.0,2.0,-1.0,,BCRX
224,,2017-01-24 09:25:16,2017-01-20,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$5.95,-5083,104706,-5%,"-$30,244",6.0,2.0,-1.0,,BCRX
225,,2017-01-24 09:22:22,2017-01-20,BCRX,Sheridan William P,SVP - CMO,F - Tax,$5.95,-5761,82916,-6%,"-$34,278",6.0,2.0,-1.0,,BCRX
226,,2017-01-24 09:20:05,2017-01-20,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$5.95,-5198,117313,-4%,"-$30,928",6.0,2.0,-1.0,,BCRX
227,,2017-01-24 09:17:06,2017-01-20,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$5.95,-10572,645418,-2%,"-$62,903",6.0,2.0,-1.0,,BCRX
228,,2017-01-03 14:13:48,2017-01-01,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$6.33,-1281,78096,-2%,"-$8,109",1.0,0.0,-2.0,,BCRX
229,,2017-01-03 14:09:44,2017-01-01,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$6.33,-1639,109789,-1%,"-$10,375",1.0,0.0,-2.0,,BCRX
230,,2017-01-03 14:06:42,2017-01-01,BCRX,Sheridan William P,SVP - CMO,F - Tax,$6.33,-2081,88677,-2%,"-$13,173",1.0,0.0,-2.0,,BCRX
231,,2017-01-03 14:03:37,2017-01-01,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$6.33,-1676,122511,-1%,"-$10,609",1.0,0.0,-2.0,,BCRX
232,,2017-01-03 13:59:01,2017-01-01,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$6.33,-8595,655990,-1%,"-$54,406",1.0,0.0,-2.0,,BCRX
233,D,2016-12-21 10:42:49,2016-12-19,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.78,3250,124187,+3%,"+$12,285",-4.0,-4.0,-14.0,,BCRX
234,D,2016-12-21 10:42:49,2016-12-19,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$7.45,-3250,124187,-3%,"-$24,213",-4.0,-4.0,-14.0,,BCRX
235,,2016-12-02 14:09:39,2016-12-01,BCRX,Ingram Robert Alexander,Dir,A - Grant,$5.59,1788,4221,+73%,"+$9,995",6.0,9.0,23.0,,BCRX
236,,2016-12-02 14:06:32,2016-12-01,BCRX,Hutson Nancy J,Dir,A - Grant,$5.59,1788,28664,+7%,"+$9,995",6.0,9.0,23.0,,BCRX
237,,2016-12-02 14:03:11,2016-12-01,BCRX,Cohen Fred E,Dir,A - Grant,$5.59,1788,115867,+2%,"+$9,995",6.0,9.0,23.0,,BCRX
238,,2016-09-16 10:54:26,2016-09-14,BCRX,Barnes Alane P,"VP, GC, Corp Sec",S - Sale,$4.27,-8357,79377,-10%,"-$35,684",-1.0,6.0,-10.0,96.0,BCRX
239,,2016-09-06 15:27:37,2016-09-01,BCRX,Ingram Robert Alexander,Dir,A - Grant,$4.11,2433,2433,New,"+$10,000",0.0,5.0,8.0,85.0,BCRX
240,,2016-09-06 15:25:47,2016-09-01,BCRX,Hutson Nancy J,Dir,A - Grant,$4.11,2433,26876,+10%,"+$10,000",0.0,5.0,8.0,85.0,BCRX
241,,2016-09-06 15:24:11,2016-09-01,BCRX,Cohen Fred E,Dir,A - Grant,$4.11,2433,114079,+2%,"+$10,000",0.0,5.0,8.0,85.0,BCRX
242,,2016-08-29 10:46:50,2016-08-25,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,S - Sale,$4.06,-30000,111428,-21%,"-$121,800",-1.0,0.0,14.0,49.0,BCRX
243,M,2016-08-16 18:11:38,2016-08-12,BCRX,Baker Bros. Advisors LP,10%,S - Sale,$5.00,-4046590,9465308,-30%,"-$20,251,103",-1.0,2.0,-2.0,30.0,BCRX
244,M,2016-08-15 14:07:46,2016-08-11,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale,$5.18,-5864,124187,-5%,"-$30,388",-6.0,-14.0,-16.0,16.0,BCRX
245,,2016-08-11 13:53:15,2016-08-09,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale,$4.43,-14577,130051,-10%,"-$64,576",1.0,-14.0,-13.0,20.0,BCRX
246,,2016-06-02 09:45:13,2016-05-31,BCRX,Hutson Nancy J,Dir,A - Grant,$3.39,2581,24443,+12%,"+$8,750",4.0,12.0,-18.0,63.0,BCRX
247,,2016-06-02 09:42:03,2016-05-31,BCRX,Cohen Fred E,Dir,A - Grant,$3.39,2581,111646,+2%,"+$8,750",4.0,12.0,-18.0,63.0,BCRX
248,,2016-03-03 09:56:01,2016-03-01,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$2.13,-687,85416,-1%,"-$1,463",4.0,10.0,13.0,65.0,BCRX
249,,2016-03-03 09:47:15,2016-03-01,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$2.13,-906,141428,-1%,"-$1,930",4.0,10.0,13.0,65.0,BCRX
250,,2016-03-03 09:45:32,2016-03-01,BCRX,Sheridan William P,SVP - CMO,F - Tax,$2.13,-799,90052,-1%,"-$1,702",4.0,10.0,13.0,65.0,BCRX
251,,2016-03-03 09:43:50,2016-03-01,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$2.13,-465,144628,0%,-$990,4.0,10.0,13.0,65.0,BCRX
252,,2016-03-03 09:41:55,2016-03-01,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$2.13,-2761,664585,0%,"-$5,881",4.0,10.0,13.0,65.0,BCRX
253,,2016-03-01 16:08:04,2016-02-29,BCRX,Sanders Charles A,Dir,A - Grant,$1.99,4396,12971,+51%,"+$8,748",18.0,43.0,31.0,103.0,BCRX
254,,2016-03-01 16:05:25,2016-02-29,BCRX,Hutson Nancy J,Dir,A - Grant,$1.99,4396,21862,+25%,"+$8,748",18.0,43.0,31.0,103.0,BCRX
255,,2016-03-01 16:03:42,2016-02-29,BCRX,Cohen Fred E,Dir,A - Grant,$1.99,4396,109065,+4%,"+$8,748",18.0,43.0,31.0,103.0,BCRX
256,,2016-02-09 17:24:41,2016-02-05,BCRX,Baker Bros. Advisors LP,10%,P - Purchase,$6.33,45000,15063285,0%,"+$284,657",-5.0,-2.0,49.0,129.0,BCRX
257,M,2016-02-04 17:15:27,2016-02-02,BCRX,Baker Bros. Advisors LP,10%,P - Purchase,$6.43,207715,15018285,+1%,"+$1,336,586",-6.0,-72.0,-60.0,-38.0,BCRX
258,D,2016-02-01 14:34:47,2016-01-29,BCRX,Barnes Alane P,"VP, GC, Corp Sec",M - OptEx,$1.42,19368,85057,+29%,"+$27,503",-1.0,-12.0,-69.0,-48.0,BCRX
259,M,2016-01-29 16:42:12,2016-01-27,BCRX,Baker Bros. Advisors LP,10%,P - Purchase,$6.95,88345,14810570,+1%,"+$613,986",-1.0,-7.0,-73.0,-52.0,BCRX
260,,2016-01-27 13:41:21,2016-01-26,BCRX,Powell Lynne,SVP - CCO,F - Tax,$7.29,-3850,8605,-31%,"-$28,067",-4.0,-11.0,-73.0,-59.0,BCRX
261,M,2016-01-25 18:10:32,2016-01-21,BCRX,Baker Bros. Advisors LP,10%,P - Purchase,$7.28,106800,14722225,+1%,"+$777,757",-3.0,-7.0,-76.0,-60.0,BCRX
262,,2016-01-22 09:27:03,2016-01-20,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$7.55,-2599,65689,-4%,"-$19,622",5.0,-3.0,-69.0,-58.0,BCRX
263,,2016-01-22 09:24:31,2016-01-20,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$7.55,-4724,142334,-3%,"-$35,666",5.0,-3.0,-69.0,-58.0,BCRX
264,,2016-01-22 09:21:56,2016-01-20,BCRX,Sheridan William P,SVP - CMO,F - Tax,$7.55,-5359,88967,-6%,"-$40,460",5.0,-3.0,-69.0,-58.0,BCRX
265,,2016-01-22 09:18:55,2016-01-20,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$7.55,-4823,145093,-3%,"-$36,414",5.0,-3.0,-69.0,-58.0,BCRX
266,,2016-01-22 09:16:49,2016-01-20,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$7.55,-10624,665702,-2%,"-$80,211",5.0,-3.0,-69.0,-58.0,BCRX
267,D,2016-01-21 13:12:56,2016-01-20,BCRX,Stonehouse Jon P,"Pres, CEO",M - OptEx,$4.15,24096,676326,+4%,"+$99,998",-7.0,-7.0,-73.0,-61.0,BCRX
268,D,2016-01-21 11:04:23,2016-01-19,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$1.81,15000,149916,+11%,"+$27,200",-7.0,-7.0,-73.0,-61.0,BCRX
269,M,2016-01-20 19:13:25,2016-01-15,BCRX,Baker Bros. Advisors LP,10%,P - Purchase,$7.28,344895,27009110,+1%,"+$2,510,143",-7.0,-4.0,-79.0,-67.0,BCRX
270,,2016-01-05 13:31:29,2016-01-01,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$10.32,-1281,68288,-2%,"-$13,220",-1.0,-21.0,-33.0,-70.0,BCRX
271,,2016-01-05 13:29:29,2016-01-01,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$10.32,-1639,147058,-1%,"-$16,914",-1.0,-21.0,-33.0,-70.0,BCRX
272,,2016-01-05 13:27:34,2016-01-01,BCRX,Sheridan William P,SVP - CMO,F - Tax,$10.32,-2081,94326,-2%,"-$21,476",-1.0,-21.0,-33.0,-70.0,BCRX
273,,2016-01-05 13:25:37,2016-01-01,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$10.32,-1676,134916,-1%,"-$17,296",-1.0,-21.0,-33.0,-70.0,BCRX
274,,2016-01-05 13:23:18,2016-01-01,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$10.32,-8091,652230,-1%,"-$83,499",-1.0,-21.0,-33.0,-70.0,BCRX
275,,2015-12-22 15:45:44,2015-12-21,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale,$10.86,-3052,136592,-2%,"-$33,145",-3.0,-1.0,-32.0,-74.0,BCRX
276,,2015-12-18 14:54:17,2015-12-17,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale,$10.49,-3000,139644,-2%,"-$31,470",0.0,4.0,-27.0,-72.0,BCRX
277,,2015-12-03 16:22:48,2015-11-30,BCRX,Sanders Charles A,Dir,A - Grant,$10.61,824,8575,+11%,"+$8,743",6.0,-3.0,-3.0,-60.0,BCRX
278,,2015-12-03 16:20:58,2015-11-30,BCRX,Hutson Nancy J,Dir,A - Grant,$10.61,824,17466,+5%,"+$8,743",6.0,-3.0,-3.0,-60.0,BCRX
279,,2015-12-03 16:19:06,2015-11-30,BCRX,Cohen Fred E,Dir,A - Grant,$10.61,824,104669,+1%,"+$8,743",6.0,-3.0,-3.0,-60.0,BCRX
280,,2015-09-02 14:27:51,2015-08-31,BCRX,Sanders Charles A,Dir,A - Grant,$11.64,751,7751,+11%,"+$8,742",2.0,5.0,3.0,-77.0,BCRX
281,,2015-09-02 14:24:57,2015-08-31,BCRX,Hutson Nancy J,Dir,A - Grant,$11.64,751,16642,+5%,"+$8,742",2.0,5.0,3.0,-77.0,BCRX
282,,2015-09-02 14:22:05,2015-08-31,BCRX,Cohen Fred E,Dir,A - Grant,$11.64,751,103845,+1%,"+$8,742",2.0,5.0,3.0,-77.0,BCRX
283,,2015-07-22 17:21:18,2015-07-20,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale,$16.50,-3500,142644,-2%,"-$57,750",-1.0,0.0,-24.0,-50.0,BCRX
284,D,2015-07-17 09:45:08,2015-07-15,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$15.67,-25526,659211,-4%,"-$399,992",0.0,-3.0,-27.0,-52.0,BCRX
285,D,2015-07-17 09:45:08,2015-07-15,BCRX,Stonehouse Jon P,"Pres, CEO",M - OptEx,$11.81,33868,659211,+5%,"+$399,981",0.0,-3.0,-27.0,-52.0,BCRX
286,D,2015-06-24 16:57:50,2015-06-22,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$4.73,3750,146144,+3%,"+$17,738",1.0,4.0,8.0,-23.0,BCRX
287,D,2015-06-24 16:57:50,2015-06-22,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$16.00,-3750,146144,-3%,"-$60,000",1.0,4.0,8.0,-23.0,BCRX
288,,2015-06-22 16:51:24,2015-06-19,BCRX,Barnes Alane P,"VP, GC, Corp Sec",S - Sale,$15.00,-3000,68876,-4%,"-$45,000",-3.0,-7.0,2.0,-35.0,BCRX
289,D,2015-06-22 16:48:12,2015-06-19,BCRX,Sheridan William P,SVP - CMO,M - OptEx,$1.20,70389,95123,+285%,"+$84,467",-3.0,-7.0,2.0,-35.0,BCRX
290,D,2015-06-22 16:48:12,2015-06-19,BCRX,Sheridan William P,SVP - CMO,S - Sale+OE,$15.05,-70389,95123,-43%,"-$1,059,354",-3.0,-7.0,2.0,-35.0,BCRX
291,DM,2015-06-22 16:38:00,2015-06-18,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.78,9375,146144,+7%,"+$35,438",-3.0,-7.0,2.0,-35.0,BCRX
292,DM,2015-06-22 16:38:00,2015-06-18,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$14.36,-16375,146144,-10%,"-$235,150",-3.0,-7.0,2.0,-35.0,BCRX
293,D,2015-06-22 16:34:54,2015-06-19,BCRX,Stonehouse Jon P,"Pres, CEO",M - OptEx,$1.20,20000,650869,+3%,"+$24,000",-3.0,-7.0,2.0,-35.0,BCRX
294,D,2015-06-22 16:34:54,2015-06-19,BCRX,Stonehouse Jon P,"Pres, CEO",S - Sale+OE,$15.02,-20000,650869,-3%,"-$300,400",-3.0,-7.0,2.0,-35.0,BCRX
295,,2015-06-09 13:33:21,2015-06-05,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale,$12.75,-6000,153144,-4%,"-$76,500",-1.0,-5.0,15.0,-17.0,BCRX
296,,2015-06-02 14:57:08,2015-06-01,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale,$12.00,-3000,159144,-2%,"-$36,000",1.0,10.0,26.0,-13.0,BCRX
297,,2015-06-01 15:53:53,2015-05-29,BCRX,Cohen Fred E,Dir,A - Grant,$11.21,780,103094,+1%,"+$8,744",6.0,16.0,29.0,-9.0,BCRX
298,,2015-05-19 16:53:03,2015-05-18,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale,$11.00,-3000,162144,-2%,"-$33,000",2.0,1.0,18.0,-14.0,BCRX
299,,2015-03-20 16:30:05,2015-03-19,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,S - Sale,$10.16,-12105,148697,-8%,"-$122,987",-5.0,-14.0,8.0,42.0,BCRX
300,,2015-03-06 14:14:04,2015-03-05,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,S - Sale,$10.59,-37400,160802,-19%,"-$396,066",-2.0,-6.0,-5.0,12.0,BCRX
301,,2015-03-05 14:58:52,2015-03-04,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,S - Sale,$10.50,-10495,198202,-5%,"-$110,198",-2.0,-8.0,-7.0,7.0,BCRX
302,,2015-03-03 15:59:04,2015-03-01,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$10.20,-1120,71876,-2%,"-$11,424",-2.0,-7.0,-12.0,11.0,BCRX
303,,2015-03-03 15:56:49,2015-03-01,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$10.20,-1634,208697,-1%,"-$16,667",-2.0,-7.0,-12.0,11.0,BCRX
304,,2015-03-03 15:54:34,2015-03-01,BCRX,Sheridan William P,SVP - CMO,F - Tax,$10.20,-1739,95123,-2%,"-$17,738",-2.0,-7.0,-12.0,11.0,BCRX
305,,2015-03-03 15:51:51,2015-03-01,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$10.20,-465,165144,0%,"-$4,743",-2.0,-7.0,-12.0,11.0,BCRX
306,,2015-03-03 15:48:21,2015-03-01,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$10.20,-5118,650869,-1%,"-$52,204",-2.0,-7.0,-12.0,11.0,BCRX
307,,2015-03-03 15:45:09,2015-02-27,BCRX,Cohen Fred E,Dir,A - Grant,$10.20,857,102314,+1%,"+$8,741",-2.0,-7.0,-12.0,11.0,BCRX
308,,2015-02-23 12:50:20,2015-02-20,BCRX,Hutson Nancy J,Dir,P - Purchase,$10.27,10000,15891,+170%,"+$102,700",4.0,0.0,-11.0,13.0,BCRX
309,D,2015-01-28 15:10:46,2015-01-26,BCRX,Powell Lynne,SVP - CCO,A - Grant,$0.00,10000,10000,New,+$0,-4.0,-4.0,-4.0,42.0,BCRX
310,,2015-01-22 12:18:20,2015-01-20,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$11.17,-2210,72370,-3%,"-$24,686",0.0,-1.0,-5.0,46.0,BCRX
311,,2015-01-22 12:16:38,2015-01-20,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$11.17,-4362,210331,-2%,"-$48,724",0.0,-1.0,-5.0,46.0,BCRX
312,,2015-01-22 12:14:46,2015-01-20,BCRX,Sheridan William P,SVP - CMO,F - Tax,$11.17,-5074,95609,-5%,"-$56,677",0.0,-1.0,-5.0,46.0,BCRX
313,,2015-01-22 12:12:59,2015-01-20,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$11.17,-4476,164913,-3%,"-$49,997",0.0,-1.0,-5.0,46.0,BCRX
314,,2015-01-22 12:10:55,2015-01-20,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$11.17,-10608,654280,-2%,"-$118,491",0.0,-1.0,-5.0,46.0,BCRX
315,D,2015-01-09 13:19:15,2015-01-08,BCRX,Cohen Fred E,Dir,M - OptEx,$1.29,100000,101457,>999%,"+$129,000",0.0,-11.0,-18.0,26.0,BCRX
316,D,2015-01-05 16:12:46,2015-01-01,BCRX,Barnes Alane P,"VP, GC, Corp Sec",A - Grant,$0.00,4800,74580,+7%,+$0,-3.0,-1.0,-15.0,23.0,BCRX
317,D,2015-01-05 16:12:46,2015-01-01,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$12.16,-2453,74580,-3%,"-$29,828",-3.0,-1.0,-15.0,23.0,BCRX
318,D,2015-01-05 16:10:27,2015-01-01,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,A - Grant,$0.00,8900,214693,+4%,+$0,-3.0,-1.0,-15.0,23.0,BCRX
319,D,2015-01-05 16:10:27,2015-01-01,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$12.16,-2402,214693,-1%,"-$29,208",-3.0,-1.0,-15.0,23.0,BCRX
320,D,2015-01-05 16:07:47,2015-01-01,BCRX,Sheridan William P,SVP - CMO,A - Grant,$0.00,10900,100683,+12%,+$0,-3.0,-1.0,-15.0,23.0,BCRX
321,D,2015-01-05 16:07:47,2015-01-01,BCRX,Sheridan William P,SVP - CMO,F - Tax,$12.16,-2735,100683,-3%,"-$33,258",-3.0,-1.0,-15.0,23.0,BCRX
322,D,2015-01-05 16:05:10,2015-01-01,BCRX,Staab Thomas R II,"SVP, CFO",A - Grant,$0.00,8900,169389,+6%,+$0,-3.0,-1.0,-15.0,23.0,BCRX
323,D,2015-01-05 16:05:10,2015-01-01,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$12.16,-2453,169389,-1%,"-$29,828",-3.0,-1.0,-15.0,23.0,BCRX
324,,2015-01-05 16:03:01,2015-01-01,BCRX,Stonehouse Jon P,"Pres, CEO",A - Grant,$0.00,28400,664888,+4%,+$0,-3.0,-1.0,-15.0,23.0,BCRX
325,,2015-01-05 16:03:01,2015-01-01,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$12.16,-5652,664888,-1%,"-$68,728",-3.0,-1.0,-15.0,23.0,BCRX
326,DM,2014-12-31 14:11:48,2014-12-29,BCRX,Sheridan William P,SVP - CMO,M - OptEx,$3.34,71500,92518,+340%,"+$238,550",0.0,0.0,-16.0,20.0,BCRX
327,DM,2014-12-31 14:11:48,2014-12-29,BCRX,Sheridan William P,SVP - CMO,S - Sale+OE,$12.36,-128399,92518,-58%,"-$1,587,451",0.0,0.0,-16.0,20.0,BCRX
328,D,2014-12-31 14:09:41,2014-12-29,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.78,9500,162942,+6%,"+$35,910",0.0,0.0,-16.0,20.0,BCRX
329,D,2014-12-31 14:09:41,2014-12-29,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$12.56,-9500,162942,-6%,"-$119,320",0.0,0.0,-16.0,20.0,BCRX
330,,2014-12-03 15:41:25,2014-11-28,BCRX,Cohen Fred E,Dir,A - Grant,$10.81,809,1457,+125%,"+$8,745",0.0,-3.0,15.0,17.0,BCRX
331,,2014-09-02 16:08:03,2014-08-29,BCRX,Cohen Fred E,Dir,A - Grant,$13.50,648,648,New,"+$8,748",1.0,-5.0,-23.0,-21.0,BCRX
332,D,2014-08-29 11:04:51,2014-08-27,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$5.45,10000,162942,+7%,"+$54,500",2.0,-7.0,-21.0,-22.0,BCRX
333,D,2014-08-29 11:04:51,2014-08-27,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$13.58,-10000,162942,-6%,"-$135,800",2.0,-7.0,-21.0,-22.0,BCRX
334,D,2014-07-28 13:21:38,2014-07-25,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$11.76,-8504,162252,-5%,"-$100,007",0.0,7.0,12.0,-4.0,BCRX
335,D,2014-07-28 13:21:38,2014-07-25,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.78,26455,162252,+19%,"+$100,000",0.0,7.0,12.0,-4.0,BCRX
336,D,2014-07-02 16:33:56,2014-07-01,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$4.73,3125,144301,+2%,"+$14,781",-1.0,-8.0,-3.0,-6.0,BCRX
337,D,2014-07-02 16:33:56,2014-07-01,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$13.00,-3125,144301,-2%,"-$40,625",-1.0,-8.0,-3.0,-6.0,BCRX
338,D,2014-06-24 15:41:22,2014-06-23,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$4.73,3125,144301,+2%,"+$14,781",0.0,6.0,1.0,-7.0,BCRX
339,D,2014-06-24 15:41:22,2014-06-23,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$12.49,-3125,144301,-2%,"-$39,031",0.0,6.0,1.0,-7.0,BCRX
340,D,2014-06-19 16:47:59,2014-06-17,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$4.73,3125,144301,+2%,"+$14,781",2.0,5.0,-3.0,-12.0,BCRX
341,D,2014-06-19 16:47:59,2014-06-17,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$12.00,-3125,144301,-2%,"-$37,500",2.0,5.0,-3.0,-12.0,BCRX
342,D,2014-06-05 14:15:05,2014-06-03,BCRX,Sheridan William P,SVP - CMO,F - Tax,$9.86,-10177,148173,-6%,"-$100,345",5.0,16.0,25.0,4.0,BCRX
343,D,2014-06-05 14:15:05,2014-06-03,BCRX,Sheridan William P,SVP - CMO,M - OptEx,$4.73,21228,148173,+17%,"+$100,333",5.0,16.0,25.0,4.0,BCRX
344,D,2014-05-27 16:03:37,2014-05-22,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.78,17685,144301,+14%,"+$66,849",-1.0,-7.0,20.0,2.0,BCRX
345,D,2014-05-12 15:38:22,2014-05-09,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$7.70,-30214,640445,-5%,"-$232,648",0.0,8.0,47.0,34.0,BCRX
346,D,2014-05-12 15:38:22,2014-05-09,BCRX,Stonehouse Jon P,"Pres, CEO",M - OptEx,$5.76,40417,640445,+7%,"+$232,635",0.0,8.0,47.0,34.0,BCRX
347,D,2014-04-01 10:37:51,2014-03-31,BCRX,Abercrombie George B,Dir,M - OptEx,$1.71,4000,10000,+67%,"+$6,840",3.0,-12.0,-19.0,-1.0,BCRX
348,D,2014-03-17 14:52:11,2014-03-14,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$4.73,3125,126616,+3%,"+$14,781",-4.0,-3.0,-26.0,7.0,BCRX
349,D,2014-03-17 14:52:11,2014-03-14,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$11.24,-3125,126616,-2%,"-$35,125",-4.0,-3.0,-26.0,7.0,BCRX
350,D,2014-03-07 16:17:00,2014-03-06,BCRX,Lee Kenneth B Jr,Dir,M - OptEx,$3.80,22917,10252,-181%,"+$87,085",0.0,-4.0,-19.0,11.0,BCRX
351,D,2014-03-07 16:17:00,2014-03-06,BCRX,Lee Kenneth B Jr,Dir,S - Sale+OE,$12.69,-12665,10252,-55%,"-$160,719",0.0,-4.0,-19.0,11.0,BCRX
352,D,2014-03-07 16:14:28,2014-03-01,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$11.69,-1618,208195,-1%,"-$18,914",0.0,-4.0,-19.0,11.0,BCRX
353,D,2014-03-07 16:14:28,2014-03-04,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,M - OptEx,$8.37,28816,208195,+16%,"+$241,177",0.0,-4.0,-19.0,11.0,BCRX
354,D,2014-03-07 16:14:28,2014-03-04,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,S - Sale+OE,$12.57,-40642,208195,-16%,"-$510,870",0.0,-4.0,-19.0,11.0,BCRX
355,D,2014-03-07 16:11:25,2014-03-01,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$11.69,-1090,71622,-1%,"-$12,742",0.0,-4.0,-19.0,11.0,BCRX
356,D,2014-03-07 16:11:25,2014-03-04,BCRX,Barnes Alane P,"VP, GC, Corp Sec",M - OptEx,$4.01,31174,71622,+77%,"+$124,897",0.0,-4.0,-19.0,11.0,BCRX
357,D,2014-03-07 16:11:25,2014-03-04,BCRX,Barnes Alane P,"VP, GC, Corp Sec",S - Sale+OE,$12.63,-40734,71622,-36%,"-$514,470",0.0,-4.0,-19.0,11.0,BCRX
358,D,2014-03-07 16:02:39,2014-03-01,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$11.69,-461,126616,0%,"-$5,389",0.0,-4.0,-19.0,11.0,BCRX
359,D,2014-03-07 16:02:39,2014-03-04,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$4.73,3000,126616,+2%,"+$14,190",0.0,-4.0,-19.0,11.0,BCRX
360,D,2014-03-07 16:02:39,2014-03-04,BCRX,Staab Thomas R II,"SVP, CFO",S - Sale+OE,$12.69,-3000,126616,-2%,"-$38,070",0.0,-4.0,-19.0,11.0,BCRX
361,,2014-03-07 15:59:19,2014-03-01,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$11.69,-5118,630242,-1%,"-$59,829",-7.0,-11.0,-26.0,4.0,BCRX
362,,2014-03-07 15:56:31,2014-03-01,BCRX,Sheridan William P,SVP - CMO,F - Tax,$11.69,-1739,137122,-1%,"-$20,329",-7.0,-11.0,-26.0,4.0,BCRX
363,D,2014-02-25 14:34:52,2014-02-24,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,F - Tax,$12.20,-8170,221639,-4%,"-$99,674",10.0,7.0,-14.0,10.0,BCRX
364,D,2014-02-25 14:34:52,2014-02-24,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,M - OptEx,$4.30,23179,221639,+12%,"+$99,670",10.0,7.0,-14.0,10.0,BCRX
365,D,2014-02-04 15:59:32,2014-01-20,BCRX,Stonehouse Jon P,"Pres, CEO",A - Grant,$0.00,128000,632360,+25%,+$0,-1.0,4.0,34.0,38.0,BCRX
366,D,2014-02-04 15:57:39,2014-01-20,BCRX,Staab Thomas R II,"SVP, CFO",A - Grant,$0.00,54000,126218,+75%,+$0,-1.0,4.0,34.0,38.0,BCRX
367,D,2014-02-04 15:55:43,2014-01-20,BCRX,Sheridan William P,SVP - CMO,A - Grant,$0.00,54000,136539,+65%,+$0,-1.0,4.0,34.0,38.0,BCRX
368,D,2014-02-04 15:53:16,2014-01-20,BCRX,Barnes Alane P,"VP, GC, Corp Sec",A - Grant,$0.00,27000,81487,+50%,+$0,-1.0,4.0,34.0,38.0,BCRX
369,D,2014-02-04 15:50:31,2014-01-20,BCRX,Babu Yarlagadda S,SVP - Drug Discovery,A - Grant,$0.00,54000,206630,+35%,+$0,-1.0,4.0,34.0,38.0,BCRX
370,D,2014-01-15 08:55:02,2014-01-14,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$10.87,-1491,54487,-3%,"-$16,207",-4.0,6.0,-13.0,-3.0,BCRX
371,D,2014-01-15 08:55:02,2014-01-14,BCRX,Barnes Alane P,"VP, GC, Corp Sec",M - OptEx,$1.20,13500,54487,+33%,"+$16,200",-4.0,6.0,-13.0,-3.0,BCRX
372,D,2014-01-15 08:51:39,2014-01-13,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$10.55,-12621,72218,-15%,"-$133,152",-4.0,6.0,-13.0,-3.0,BCRX
373,D,2014-01-15 08:51:39,2014-01-13,BCRX,Staab Thomas R II,"SVP, CFO",M - OptEx,$3.78,35225,72218,+95%,"+$133,151",-4.0,6.0,-13.0,-3.0,BCRX
374,,2014-01-03 15:59:17,2014-01-01,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$7.60,-8592,504360,-2%,"-$65,299",7.0,25.0,21.0,61.0,BCRX
375,,2014-01-03 15:56:45,2014-01-01,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$7.60,-2453,49614,-5%,"-$18,643",7.0,25.0,21.0,61.0,BCRX
376,,2014-01-03 15:55:15,2014-01-01,BCRX,Sheridan William P,SVP - CMO,F - Tax,$7.60,-2735,82539,-3%,"-$20,786",7.0,25.0,21.0,61.0,BCRX
377,,2014-01-03 15:52:57,2014-01-01,BCRX,Barnes Alane P,"VP, GC, Corp Sec",F - Tax,$7.60,-2453,42478,-5%,"-$18,643",7.0,25.0,21.0,61.0,BCRX
378,,2014-01-03 15:51:05,2014-01-01,BCRX,Babu Yarlagadda S,VP Drug Discovery,F - Tax,$7.60,-2402,152630,-2%,"-$18,255",7.0,25.0,21.0,61.0,BCRX
379,,2013-11-13 16:25:19,2013-11-12,BCRX,Abercrombie George B,Dir,P - Purchase,$6.19,3000,6000,+100%,"+$18,570",0.0,-4.0,2.0,48.0,BCRX
380,,2013-08-02 16:00:06,2013-08-01,BCRX,Baker Felix,10%,P - Purchase,$4.40,1136364,225181,-125%,"+$5,000,002",3.0,-8.0,9.0,81.0,BCRX
381,D,2013-05-29 16:00:36,2013-05-28,BCRX,Sheridan William P,SVP - CMO,M - OptEx,$1.20,16407,82274,+25%,"+$19,688",-1.0,-2.0,-15.0,254.0,BCRX
382,D,2013-05-28 13:55:42,2013-05-23,BCRX,Stonehouse Jon P,"Pres, CEO",M - OptEx,$1.20,179600,509952,+54%,"+$215,520",0.0,8.0,-6.0,260.0,BCRX
383,A,2013-04-12 13:46:15,2013-01-01,BCRX,Stonehouse Jon P,"Pres, CEO",A - Grant,$0.00,62600,333319,+23%,+$0,14.0,10.0,8.0,288.0,BCRX
384,,2013-03-14 16:34:55,2013-01-31,BCRX,Stonehouse Jon P,"Pres, CEO",A - Grant,$1.38,3000,340225,+1%,"+$4,140",-1.0,-5.0,46.0,427.0,BCRX
385,,2013-03-14 16:32:17,2013-01-31,BCRX,Staab Thomas R II,"SVP, CFO",A - Grant,$1.38,2745,52609,+6%,"+$3,788",-1.0,-5.0,46.0,427.0,BCRX
386,,2013-03-14 16:30:11,2013-01-31,BCRX,Sheridan William P,SVP - CMO,A - Grant,$1.38,3000,67656,+5%,"+$4,140",-1.0,-5.0,46.0,427.0,BCRX
387,,2013-03-06 16:45:54,2013-03-05,BCRX,Abercrombie George B,Dir,P - Purchase,$1.23,3000,3000,New,"+$3,690",3.0,2.0,7.0,430.0,BCRX
388,,2013-03-06 16:44:33,2013-03-01,BCRX,Sheridan William P,SVP - CMO,F - Tax,$1.19,-1789,62867,-3%,"-$2,129",3.0,2.0,7.0,430.0,BCRX
389,,2013-03-06 16:42:48,2013-03-01,BCRX,Babu Yarlagadda S,VP Drug Discovery,F - Tax,$1.19,-1903,155032,-1%,"-$2,265",3.0,2.0,7.0,430.0,BCRX
390,,2013-03-06 16:41:22,2013-03-01,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$1.19,-542,49322,-1%,-$645,3.0,2.0,7.0,430.0,BCRX
391,,2013-03-06 16:38:59,2013-03-01,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$1.19,-5967,331258,-2%,"-$7,101",3.0,2.0,7.0,430.0,BCRX
392,D,2013-01-07 15:12:25,2013-01-01,BCRX,Stonehouse Jon P,"Pres, CEO",A - Grant,$0.00,66506,337225,+25%,+$0,-1.0,11.0,-4.0,-2.0,BCRX
393,D,2013-01-07 15:10:43,2013-01-01,BCRX,Staab Thomas R II,"SVP, CFO",A - Grant,$0.00,17000,49864,+52%,+$0,-1.0,11.0,-4.0,-2.0,BCRX
394,D,2013-01-07 15:08:50,2013-01-01,BCRX,Sheridan William P,SVP - CMO,A - Grant,$0.00,17000,64656,+36%,+$0,-1.0,11.0,-4.0,-2.0,BCRX
395,D,2013-01-07 15:05:58,2013-01-01,BCRX,Babu Yarlagadda S,VP Drug Discovery,A - Grant,$0.00,17000,156935,+12%,+$0,-1.0,11.0,-4.0,-2.0,BCRX
396,,2012-12-17 12:10:42,2012-12-14,BCRX,Jensen Peder,Dir,P - Purchase,$1.51,20000,60000,+50%,"+$30,200",2.0,5.0,15.0,19.0,BCRX
397,,2012-07-02 14:49:26,2012-07-01,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$3.97,-8113,31617,-20%,"-$32,209",2.0,-2.0,12.0,-59.0,BCRX
398,,2012-06-05 19:38:00,2012-06-05,BCRX,Jensen Peder,Dir,P - Purchase,$3.18,20000,40000,+100%,"+$63,680",12.0,13.0,29.0,-54.0,BCRX
399,,2012-03-19 16:11:23,2012-03-15,BCRX,Stonehouse Jon P,"Pres, CEO",A - Grant,$0.00,41947,267719,+19%,+$0,-3.0,-4.0,-26.0,-18.0,BCRX
400,,2012-03-19 16:11:23,2012-03-15,BCRX,Stonehouse Jon P,"Pres, CEO",F - Tax,$5.23,-13612,267719,-5%,"-$71,191",-3.0,-4.0,-26.0,-18.0,BCRX
401,,2012-03-19 16:07:46,2012-03-15,BCRX,Staab Thomas R II,"SVP, CFO",A - Grant,$0.00,11989,37124,+48%,+$0,-3.0,-4.0,-26.0,-18.0,BCRX
402,,2012-03-19 16:07:46,2012-03-15,BCRX,Staab Thomas R II,"SVP, CFO",F - Tax,$5.23,-4162,37124,-10%,"-$21,767",-3.0,-4.0,-26.0,-18.0,BCRX
403,,2012-03-19 13:12:21,2012-03-15,BCRX,McCullough David,VP,A - Grant,$0.00,15505,24124,+180%,+$0,1.0,-4.0,-25.0,-18.0,BCRX
404,,2012-03-19 13:12:21,2012-03-15,BCRX,McCullough David,VP,F - Tax,$5.23,-5307,24124,-18%,"-$27,756",1.0,-4.0,-25.0,-18.0,BCRX
405,,2012-03-19 13:10:15,2012-03-15,BCRX,Lowrey Robert S,"Controller, PAO",A - Grant,$0.00,7327,9766,+300%,+$0,1.0,-4.0,-25.0,-18.0,BCRX
406,,2012-03-19 13:10:15,2012-03-15,BCRX,Lowrey Robert S,"Controller, PAO",F - Tax,$5.23,-2686,9766,-22%,"-$14,048",1.0,-4.0,-25.0,-18.0,BCRX
407,,2012-03-19 12:19:42,2012-03-15,BCRX,Babu Yarlagadda S,VP Drug Discovery,A - Grant,$0.00,21038,139935,+18%,+$0,1.0,-4.0,-25.0,-18.0,BCRX
408,,2012-03-19 12:19:42,2012-03-15,BCRX,Babu Yarlagadda S,VP Drug Discovery,F - Tax,$5.23,-6872,139935,-5%,"-$35,941",1.0,-4.0,-25.0,-18.0,BCRX
409,,2012-03-19 11:48:47,2012-03-15,BCRX,Sheridan William P,SVP - CMO,A - Grant,$0.00,22869,44656,+105%,+$0,1.0,-4.0,-25.0,-18.0,BCRX
410,,2012-03-19 11:48:47,2012-03-15,BCRX,Sheridan William P,SVP - CMO,F - Tax,$5.23,-7543,44656,-14%,"-$39,450",1.0,-4.0,-25.0,-18.0,BCRX
411,A,2012-03-15 15:21:49,2012-03-13,BCRX,Sanders Charles A,Dir,P - Purchase,$5.20,2000,7000,+40%,"+$10,400",-2.0,-2.0,-27.0,-23.0,BCRX
412,,2012-03-15 12:21:32,2012-03-13,BCRX,Sanders Charles A,Dir,P - Purchase,$5.22,2000,7000,+40%,"+$10,430",-2.0,-2.0,-27.0,-23.0,BCRX
413,D,2012-03-05 17:09:23,2012-03-01,BCRX,Stonehouse Jon P,"Pres, CEO",A - Grant,$0.00,33253,239384,+16%,+$0,1.0,0.0,-13.0,-28.0,BCRX
414,D,2012-03-05 17:09:23,2012-03-02,BCRX,Stonehouse Jon P,"Pres, CEO",S - Sale+OE,$4.78,-2721,239384,-1%,"-$13,006",1.0,0.0,-13.0,-28.0,BCRX
415,D,2012-03-05 15:41:50,2012-03-01,BCRX,Staab Thomas R II,"SVP, CFO",A - Grant,$0.00,5600,30600,+22%,+$0,19.0,19.0,6.0,-9.0,BCRX
416,D,2012-03-05 15:38:32,2012-03-01,BCRX,Sheridan William P,SVP - CMO,A - Grant,$0.00,8500,29330,+41%,+$0,19.0,19.0,6.0,-9.0,BCRX
417,D,2012-03-05 15:38:32,2012-03-02,BCRX,Sheridan William P,SVP - CMO,S - Sale+OE,$4.78,-956,29330,-3%,"-$4,570",19.0,19.0,6.0,-9.0,BCRX
418,D,2012-03-05 14:58:47,2012-03-01,BCRX,McCullough David,VP,A - Grant,$0.00,8500,13926,+157%,+$0,19.0,19.0,6.0,-9.0,BCRX
419,D,2012-03-05 14:58:47,2012-03-02,BCRX,McCullough David,VP,S - Sale+OE,$4.78,-574,13926,-4%,"-$2,744",19.0,19.0,6.0,-9.0,BCRX
420,D,2012-03-05 14:50:27,2012-03-01,BCRX,Lowrey Robert S,"Controller, PAO",A - Grant,$0.00,5125,5125,New,+$0,19.0,19.0,6.0,-9.0,BCRX
421,D,2012-03-05 14:30:58,2012-03-01,BCRX,Babu Yarlagadda S,VP Drug Discovery,A - Grant,$0.00,11200,125769,+10%,+$0,19.0,19.0,6.0,-9.0,BCRX
422,D,2012-03-05 14:30:58,2012-03-02,BCRX,Babu Yarlagadda S,VP Drug Discovery,S - Sale+OE,$4.78,-837,125769,-1%,"-$4,001",19.0,19.0,6.0,-9.0,BCRX
423,D,2012-03-01 14:59:24,2012-02-29,BCRX,Babu Yarlagadda S,VP Drug Discovery,M - OptEx,$0.00,53668,106406,+102%,+$0,2.0,20.0,10.0,-11.0,BCRX
424,D,2012-02-23 16:40:41,2012-02-22,BCRX,Babu Yarlagadda S,VP Drug Discovery,M - OptEx,$1.19,30912,52738,+142%,"+$36,781",2.0,11.0,26.0,-5.0,BCRX
425,D,2012-02-23 16:40:41,2012-02-22,BCRX,Babu Yarlagadda S,VP Drug Discovery,S - Sale+OE,$4.22,-30912,52738,-37%,"-$130,449",2.0,11.0,26.0,-5.0,BCRX
426,D,2012-01-05 13:47:17,2012-01-03,BCRX,McCullough David,VP,M - OptEx,$1.20,60624,6000,-111%,"+$72,749",3.0,4.0,67.0,63.0,BCRX
427,D,2012-01-05 13:47:17,2012-01-03,BCRX,McCullough David,VP,S - Sale+OE,$2.45,-60624,6000,-91%,"-$148,529",3.0,4.0,67.0,63.0,BCRX
428,,2011-12-08 14:41:34,2011-12-07,BCRX,McCullough David,VP,S - Sale,$2.85,-4542,6000,-43%,"-$12,945",-5.0,-13.0,-13.0,24.0,BCRX
429,,2011-11-18 14:52:34,2011-11-18,BCRX,Jensen Peder,Dir,P - Purchase,$2.75,10000,20000,+100%,"+$27,500",4.0,-3.0,-11.0,25.0,BCRX
430,,2011-08-09 13:55:23,2011-08-08,BCRX,Stonehouse Jon P,"Pres, CEO",P - Purchase,$2.52,10000,217492,+5%,"+$25,190",14.0,18.0,30.0,68.0,BCRX
431,D,2011-07-08 14:01:51,2011-07-01,BCRX,Staab Thomas R II,"SVP, CFO",A - Grant,$0.00,25000,25000,New,+$0,2.0,2.0,-30.0,-36.0,BCRX
432,D,2011-05-16 18:01:55,2011-05-12,BCRX,Jensen Peder,Dir,P - Purchase,$3.56,10000,10000,New,"+$35,600",-1.0,-1.0,20.0,-13.0,BCRX
433,D,2011-03-18 16:49:38,2011-03-16,BCRX,Grant Stuart,"SVP, CFO",M - OptEx,$1.20,65000,57102,-823%,"+$78,000",2.0,1.0,6.0,-15.0,BCRX
434,D,2011-03-18 16:49:38,2011-03-16,BCRX,Grant Stuart,"SVP, CFO",S - Sale+OE,$3.39,-22615,57102,-28%,"-$76,725",2.0,1.0,6.0,-15.0,BCRX
435,,2011-03-18 16:25:30,2011-03-18,BCRX,Stonehouse Jon P,"Pres, CEO",P - Purchase,$3.40,10000,194180,+5%,"+$33,988",2.0,1.0,6.0,-15.0,BCRX
436,D,2011-03-03 15:26:31,2011-03-01,BCRX,Stonehouse Jon P,"Pres, CEO",A - Grant,$0.00,28500,184180,+18%,+$0,-1.0,-3.0,-10.0,-20.0,BCRX
437,D,2011-03-03 15:18:34,2011-03-01,BCRX,Sheridan William P,SVP - CMO,A - Grant,$0.00,10000,15786,+173%,+$0,-1.0,-3.0,-10.0,-20.0,BCRX
438,D,2011-03-03 15:03:51,2011-03-01,BCRX,McCullough David,VP,A - Grant,$0.00,6000,11626,+107%,+$0,-1.0,-3.0,-10.0,-20.0,BCRX
439,D,2011-03-03 14:52:57,2011-03-01,BCRX,Babu Yarlagadda S,VP Drug Discovery,A - Grant,$0.00,9000,61738,+17%,+$0,-1.0,-3.0,-10.0,-20.0,BCRX
440,D,2010-08-06 12:42:14,2010-08-04,BCRX,Grant Stuart,"SVP, CFO",M - OptEx,$1.20,2500,11717,+27%,"+$3,000",-3.0,-12.0,-8.0,-27.0,BCRX
441,D,2010-08-06 12:42:14,2010-08-04,BCRX,Grant Stuart,"SVP, CFO",S - Sale+OE,$6.20,-2500,11717,-18%,"-$15,500",-3.0,-12.0,-8.0,-27.0,BCRX
442,D,2010-06-04 13:21:57,2010-06-03,BCRX,Grant Stuart,"SVP, CFO",M - OptEx,$1.20,1250,11717,+12%,"+$1,500",-4.0,-11.0,-19.0,-29.0,BCRX
443,D,2010-06-04 13:21:57,2010-06-03,BCRX,Grant Stuart,"SVP, CFO",S - Sale+OE,$6.97,-1250,11717,-10%,"-$8,713",-4.0,-11.0,-19.0,-29.0,BCRX
444,D,2010-05-05 13:39:17,2010-05-03,BCRX,Grant Stuart,"SVP, CFO",M - OptEx,$1.20,1250,11717,+12%,"+$1,500",1.0,-3.0,-7.0,-36.0,BCRX
445,D,2010-05-05 13:39:17,2010-05-03,BCRX,Grant Stuart,"SVP, CFO",S - Sale+OE,$7.68,-1250,11717,-10%,"-$9,600",1.0,-3.0,-7.0,-36.0,BCRX
446,DM,2010-04-30 11:09:16,2010-04-28,BCRX,Grant Stuart,"SVP, CFO",M - OptEx,$3.26,38553,9000,-130%,"+$125,683",-8.0,-12.0,-15.0,-40.0,BCRX
447,DM,2010-04-30 11:09:16,2010-04-28,BCRX,Grant Stuart,"SVP, CFO",S - Sale+OE,$8.31,-38553,9000,-81%,"-$320,297",-8.0,-12.0,-15.0,-40.0,BCRX
448,D,2010-04-14 15:16:06,2010-04-12,BCRX,Grant Stuart,"SVP, CFO",M - OptEx,$3.26,509,11717,+5%,"+$1,659",1.0,-5.0,-11.0,-37.0,BCRX
449,D,2010-04-14 15:16:06,2010-04-12,BCRX,Grant Stuart,"SVP, CFO",S - Sale+OE,$8.26,-509,11717,-4%,"-$4,204",1.0,-5.0,-11.0,-37.0,BCRX
450,D,2010-04-12 14:05:48,2010-04-08,BCRX,Sheridan William P,SVP - CMO,M - OptEx,$2.13,18593,1664,-110%,"+$39,562",1.0,-7.0,-9.0,-40.0,BCRX
451,D,2010-04-12 14:05:48,2010-04-08,BCRX,Sheridan William P,SVP - CMO,S - Sale+OE,$8.01,-18593,1664,-92%,"-$148,856",1.0,-7.0,-9.0,-40.0,BCRX
452,D,2010-04-06 14:55:26,2010-04-05,BCRX,Grant Stuart,"SVP, CFO",M - OptEx,$1.20,1249,11717,+12%,"+$1,499",2.0,14.0,4.0,-31.0,BCRX
453,D,2010-04-06 14:55:26,2010-04-05,BCRX,Grant Stuart,"SVP, CFO",S - Sale+OE,$6.96,-1249,11717,-10%,"-$8,693",2.0,14.0,4.0,-31.0,BCRX
454,D,2010-03-16 19:05:55,2010-03-15,BCRX,Horovitz Zola P,Dir,M - OptEx,$2.60,10000,3000,-143%,"+$26,000",1.0,-6.0,13.0,-22.0,BCRX
455,D,2010-03-16 19:05:55,2010-03-15,BCRX,Horovitz Zola P,Dir,S - Sale+OE,$7.22,-10000,3000,-77%,"-$72,150",1.0,-6.0,13.0,-22.0,BCRX
456,D,2010-03-12 16:34:17,2010-03-12,BCRX,Mills Mike,Principal Accounting Officer,M - OptEx,$1.20,1500,0,-100%,"+$1,800",-3.0,-3.0,12.0,-28.0,BCRX
457,D,2010-03-12 16:34:17,2010-03-12,BCRX,Mills Mike,Principal Accounting Officer,S - Sale+OE,$7.31,-1500,0,-100%,"-$10,967",-3.0,-3.0,12.0,-28.0,BCRX
458,D,2010-03-04 18:09:38,2010-03-03,BCRX,Grant Stuart,"SVP, CFO",M - OptEx,$1.20,15000,9000,-250%,"+$18,000",3.0,9.0,2.0,-29.0,BCRX
459,D,2010-03-04 18:09:38,2010-03-03,BCRX,Grant Stuart,"SVP, CFO",S - Sale+OE,$6.96,-15000,9000,-63%,"-$104,370",3.0,9.0,2.0,-29.0,BCRX
460,D,2010-02-11 16:28:12,2010-02-10,BCRX,Mills Mike,Principal Accounting Officer,M - OptEx,$4.10,5146,0,-100%,"+$21,096",0.0,-5.0,1.0,-30.0,BCRX
461,D,2010-02-11 16:28:12,2010-02-10,BCRX,Mills Mike,Principal Accounting Officer,S - Sale+OE,$7.05,-5146,0,-100%,"-$36,279",0.0,-5.0,1.0,-30.0,BCRX
462,,2010-02-09 16:06:29,2010-02-08,BCRX,Sanders Charles A,Dir,P - Purchase,$6.66,5000,5000,New,"+$33,300",18.0,16.0,16.0,-11.0,BCRX
463,D,2010-02-03 11:37:55,2010-02-01,BCRX,Horovitz Zola P,Dir,M - OptEx,$3.38,10000,3000,-143%,"+$33,800",-1.0,-14.0,-8.0,-17.0,BCRX
464,D,2010-02-03 11:37:55,2010-02-01,BCRX,Horovitz Zola P,Dir,S - Sale+OE,$6.85,-10000,3000,-77%,"-$68,500",-1.0,-14.0,-8.0,-17.0,BCRX
465,,2010-01-25 14:18:13,2010-01-22,BCRX,Grant Stuart,"SVP, CFO",S - Sale,$7.02,-17027,9000,-65%,"-$119,530",-1.0,0.0,-4.0,-15.0,BCRX
466,,2010-01-25 14:12:50,2010-01-22,BCRX,McCullough David,VP,S - Sale,$7.02,-14271,5626,-72%,"-$100,182",-1.0,0.0,-4.0,-15.0,BCRX
467,D,2010-01-12 17:49:31,2010-01-11,BCRX,Sheridan William P,SVP - CMO,M - OptEx,$2.58,4166,0,-100%,"+$10,748",2.0,2.0,-7.0,-23.0,BCRX
468,D,2010-01-12 17:49:31,2010-01-11,BCRX,Sheridan William P,SVP - CMO,S - Sale+OE,$8.05,-4166,0,-100%,"-$33,536",2.0,2.0,-7.0,-23.0,BCRX
469,,2010-01-05 10:00:19,2009-12-31,BCRX,McCullough David,VP,F - Tax,$6.46,-4542,19897,-19%,"-$29,341",8.0,20.0,6.0,-20.0,BCRX
470,,2010-01-05 09:56:17,2009-12-31,BCRX,Grant Stuart,"SVP, CFO",F - Tax,$6.46,-7812,26027,-23%,"-$50,466",8.0,20.0,6.0,-20.0,BCRX
471,,2010-01-05 09:51:02,2009-12-31,BCRX,Babu Yarlagadda S,VP Drug Discovery,F - Tax,$6.46,-6137,52738,-10%,"-$39,645",8.0,20.0,6.0,-20.0,BCRX
472,D,2009-12-02 18:35:28,2009-12-01,BCRX,Sheridan William P,SVP - CMO,M - OptEx,$2.58,4167,0,-100%,"+$10,751",-4.0,-18.0,-20.0,-13.0,BCRX
473,D,2009-12-02 18:35:28,2009-12-01,BCRX,Sheridan William P,SVP - CMO,S - Sale+OE,$8.17,-4167,0,-100%,"-$34,044",-4.0,-18.0,-20.0,-13.0,BCRX
474,,2009-12-02 12:05:26,2009-12-01,BCRX,Featheringill William W,"Dir, 10%",S - Sale,$8.06,-147200,2965110,-5%,"-$1,186,874",-2.0,-19.0,-22.0,-15.0,BCRX
475,,2009-11-25 15:23:23,2009-11-23,BCRX,Featheringill William W,"Dir, 10%",S - Sale,$9.56,-13800,3112310,0%,"-$131,969",-3.0,-9.0,-24.0,-20.0,BCRX
476,,2009-11-23 16:56:32,2009-11-20,BCRX,Featheringill William W,"Dir, 10%",S - Sale,$9.66,-439000,3126110,-12%,"-$4,238,545",1.0,-8.0,-30.0,-19.0,BCRX
477,,2009-10-28 10:14:21,2009-10-26,BCRX,Babu Yarlagadda S,VP Drug Discovery,S - Sale,$10.85,-6400,39362,-14%,"-$69,422",-13.0,-12.0,-18.0,-21.0,BCRX
478,,2009-10-22 13:29:42,2009-10-21,BCRX,Babu Yarlagadda S,VP Drug Discovery,S - Sale,$10.00,-200,45762,0%,"-$2,000",3.0,-4.0,9.0,-23.0,BCRX
479,,2009-10-21 16:40:33,2009-10-20,BCRX,Babu Yarlagadda S,VP Drug Discovery,S - Sale,$10.00,-3400,45962,-7%,"-$34,000",3.0,11.0,14.0,-25.0,BCRX
480,D,2009-10-15 14:50:07,2009-10-14,BCRX,Sheridan William P,SVP - CMO,S - Sale+OE,$8.92,-6000,0,-100%,"-$53,540",3.0,4.0,32.0,-17.0,BCRX
481,,2009-09-24 15:23:45,2009-09-23,BCRX,Babu Yarlagadda S,VP Drug Discovery,S - Sale,$9.14,-20000,49362,-29%,"-$182,720",-10.0,-10.0,8.0,-27.0,BCRX
482,D,2009-07-24 16:56:54,2009-07-23,BCRX,Mills Mike,Principal Accounting Officer,M - OptEx,$3.26,1500,0,-100%,"+$4,890",17.0,-2.0,6.0,-31.0,BCRX
483,D,2009-07-24 16:56:54,2009-07-23,BCRX,Mills Mike,Principal Accounting Officer,S - Sale+OE,$8.26,-1500,0,-100%,"-$12,390",17.0,-2.0,6.0,-31.0,BCRX
484,,2009-07-21 11:37:09,2009-07-17,BCRX,Mills Mike,Principal Accounting Officer,S - Sale,$6.00,-968,0,-100%,"-$5,808",27.0,76.0,58.0,31.0,BCRX
485,M,2009-06-01 19:17:52,2009-05-28,BCRX,"Baker Brothers Life Sciences Capital (Gp), LLC",10%,S - Sale,$4.22,-516932,3831534,-12%,"-$2,182,226",6.0,8.0,8.0,120.0,BCRX
486,M,2009-06-01 18:51:20,2009-05-28,BCRX,"Baker Biotech Capital (Gp), LLC",10%,S - Sale,$4.22,-236478,1522015,-13%,"-$998,292",6.0,8.0,8.0,120.0,BCRX
487,M,2009-06-01 18:33:39,2009-05-28,BCRX,"14159 Capital (Gp), LLC",10%,S - Sale,$4.22,-15860,120828,-12%,"-$66,952",6.0,8.0,8.0,120.0,BCRX
488,M,2009-06-01 18:22:54,2009-05-28,BCRX,"Baker Bros. Capital (Gp), LLC",10%,S - Sale,$4.22,-37719,71997,-34%,"-$159,231",6.0,8.0,8.0,120.0,BCRX
489,M,2009-06-01 18:11:41,2009-05-28,BCRX,"Baker / Tisch Capital (Gp), LLC",10%,S - Sale,$4.22,-10085,17241,-37%,"-$42,574",6.0,8.0,8.0,120.0,BCRX
490,,2009-03-16 08:07:20,2009-03-12,BCRX,Erck Stanley C,Dir,P - Purchase,$1.22,40000,40000,New,"+$48,880",2.0,-14.0,30.0,690.0,BCRX
491,M,2009-03-05 15:06:02,2000-11-01,BCRX,Featheringill William W,Dir,P - Purchase,$9.00,11000,1808572,+1%,"+$99,000",-12.0,-12.0,26.0,755.0,BCRX
492,,2009-02-03 11:02:11,2009-01-30,BCRX,Sheridan William P,SVP - CMO,P - Purchase,$1.62,3000,3000,New,"+$4,845",-4.0,3.0,-25.0,413.0,BCRX
493,,2009-02-03 10:58:05,2009-01-30,BCRX,Grant Stuart,"SVP, CFO",P - Purchase,$1.62,3000,6000,+100%,"+$4,845",-4.0,3.0,-25.0,413.0,BCRX
494,,2009-02-03 10:53:56,2009-01-30,BCRX,Stonehouse Jon P,"Pres, CEO",P - Purchase,$1.62,3000,103603,+3%,"+$4,845",-4.0,3.0,-25.0,413.0,BCRX
495,,2008-12-02 17:56:43,2008-12-01,BCRX,Stonehouse Jon P,"Pres, CEO",P - Purchase,$1.48,55000,155603,+55%,"+$81,450",0.0,6.0,6.0,235.0,BCRX
496,M,2008-11-24 17:10:03,2008-11-20,BCRX,"Baker Bros. Capital (Gp), LLC",10%,P - Purchase,$0.99,475,109716,0%,+$471,24.0,1.0,26.0,360.0,BCRX
497,M,2008-11-24 16:55:07,2008-11-20,BCRX,"Baker Brothers Life Sciences Capital (Gp), LLC",10%,P - Purchase,$0.99,341989,4348466,+9%,"+$339,156",24.0,1.0,26.0,360.0,BCRX
498,M,2008-11-24 16:51:02,2008-11-20,BCRX,"Baker Biotech Capital (Gp), LLC",10%,P - Purchase,$0.99,108203,1758493,+7%,"+$107,307",24.0,1.0,26.0,360.0,BCRX
499,M,2008-11-24 16:47:08,2008-11-20,BCRX,"14159 Capital (Gp), LLC",10%,P - Purchase,$0.99,9327,136688,+7%,"+$9,250",24.0,1.0,26.0,360.0,BCRX
500,M,2008-11-24 16:41:40,2008-11-20,BCRX,"Baker / Tisch Capital (Gp), LLC",10%,P - Purchase,$0.99,2284,27326,+9%,"+$2,265",24.0,1.0,26.0,360.0,BCRX
501,,2008-11-03 17:34:01,2008-11-03,BCRX,Stonehouse Jon P,"Pres, CEO",P - Purchase,$1.75,25000,100603,+33%,"+$43,729",2.0,-7.0,-26.0,95.0,BCRX
502,,2008-08-13 14:58:17,2008-08-12,BCRX,Stonehouse Jon P,"Pres, CEO",P - Purchase,$3.10,2300,75603,+3%,"+$7,124",-2.0,4.0,-18.0,-45.0,BCRX
503,,2008-08-13 14:26:29,2008-08-11,BCRX,Stonehouse Jon P,"Pres, CEO",P - Purchase,$2.95,7700,73303,+12%,"+$22,736",-2.0,4.0,-18.0,-45.0,BCRX
504,,2008-08-04 18:47:05,2008-08-04,BCRX,Grant Stuart,"SVP, CFO",P - Purchase,$2.82,3000,3000,New,"+$8,466",-1.0,-13.0,9.0,-40.0,BCRX
505,,2008-08-04 18:38:22,2008-08-04,BCRX,Stonehouse Jon P,"Pres, CEO",P - Purchase,$2.82,240,65603,0%,+$677,-1.0,-13.0,9.0,-40.0,BCRX
506,,2008-08-04 18:22:12,2008-07-31,BCRX,Darwin Michael A,Principal Accounting Officer,P - Purchase,$2.82,1709,3048,+128%,"+$4,823",-1.0,-13.0,9.0,-40.0,BCRX
507,,2008-02-04 13:20:20,2008-01-31,BCRX,Stonehouse Jon P,"Pres, CEO",P - Purchase,$3.50,3000,65363,+5%,"+$10,506",11.0,-6.0,-5.0,-20.0,BCRX
508,,2008-02-04 13:04:56,2008-01-31,BCRX,Darwin Michael A,Principal Accounting Officer,P - Purchase,$3.50,1339,1339,New,"+$4,689",11.0,-6.0,-5.0,-20.0,BCRX
509,D,2007-09-06 11:08:22,2007-09-04,BCRX,Bennett J Claude,COO,M - OptEx,$6.36,20000,65730,+44%,"+$127,109",2.0,-5.0,-42.0,-70.0,BCRX
510,D,2007-09-06 11:08:22,2007-09-04,BCRX,Bennett J Claude,COO,S - Sale+OE,$12.00,-20000,65730,-23%,"-$240,000",2.0,-5.0,-42.0,-70.0,BCRX
511,M,2007-08-14 17:21:09,2007-08-13,BCRX,Stonehouse Jon P,"Pres, CEO",P - Purchase,$9.90,9900,62363,+19%,"+$97,992",5.0,5.0,20.0,-61.0,BCRX
512,D,2007-08-08 11:09:12,2007-08-06,BCRX,Featheringill William W,"Dir, 10%",P - Purchase,$7.80,831538,3554110,+31%,"+$6,485,996",3.0,7.0,37.0,-57.0,BCRX
513,,2007-08-02 17:41:42,2007-07-31,BCRX,Stonehouse Jon P,CEO,P - Purchase,$7.06,2463,52463,+5%,"+$17,376",-1.0,20.0,40.0,-48.0,BCRX
514,,2007-08-02 17:37:03,2007-07-31,BCRX,Nugent Jonathan M,VP Corp Communications,P - Purchase,$7.06,285,508,+128%,"+$2,011",-1.0,20.0,40.0,-48.0,BCRX
515,,2007-08-02 17:28:15,2007-07-31,BCRX,Alexander W James,"SVP, Chief Medical Officer",P - Purchase,$7.06,2374,3659,+185%,"+$16,749",-1.0,20.0,40.0,-48.0,BCRX
516,D,2007-04-04 17:40:15,2007-04-02,BCRX,McCullough David,VP,A - Grant,$0.00,10000,10000,New,+$0,0.0,9.0,8.0,-13.0,BCRX
517,D,2007-02-27 11:56:38,2007-02-26,BCRX,Bennett J Claude,Pres,M - OptEx,$5.89,16171,65730,+33%,"+$95,278",-5.0,-16.0,-26.0,4.0,BCRX
518,,2007-02-02 12:53:03,2007-01-31,BCRX,Nugent Jonathan M,VP Corp Communications,P - Purchase,$8.64,223,223,New,"+$1,928",0.0,7.0,-11.0,-22.0,BCRX
519,,2007-02-02 12:42:55,2007-01-31,BCRX,Riggs Randall B,SVP Business Development,P - Purchase,$8.64,1184,1928,+159%,"+$10,235",0.0,7.0,-11.0,-22.0,BCRX
520,D,2007-01-09 18:24:28,2007-01-09,BCRX,Stonehouse Jon P,CEO,A - Grant,$0.00,50000,50000,New,+$0,3.0,4.0,1.0,-24.0,BCRX
521,,2006-12-05 15:17:58,2006-08-29,BCRX,Featheringill William W,Dir,G - Gift,$9.89,-60000,2722572,-2%,"-$593,400",-3.0,-5.0,0.0,-34.0,BCRX
522,D,2006-09-05 18:44:30,2006-09-01,BCRX,Nugent Jonathan M,VP Corp Communications,M - OptEx,$4.66,5600,0,-100%,"+$26,096",-4.0,-7.0,6.0,-6.0,BCRX
523,D,2006-09-05 18:44:30,2006-09-01,BCRX,Nugent Jonathan M,VP Corp Communications,S - Sale+OE,$10.19,-5600,0,-100%,"-$57,088",-4.0,-7.0,6.0,-6.0,BCRX
524,,2006-08-15 14:09:05,2006-08-14,BCRX,Alexander W James,"SVP, Chief Medical Officer",P - Purchase,$9.00,1285,1285,New,"+$11,565",1.0,10.0,15.0,29.0,BCRX
525,,2006-08-02 17:37:50,2006-07-31,BCRX,Riggs Randall B,SVP Business Development,P - Purchase,$9.69,744,744,New,"+$7,209",1.0,-3.0,-10.0,-9.0,BCRX
526,D,2006-05-11 13:30:21,2006-05-10,BCRX,Bennett J Claude,Pres,P - Purchase,$6.50,6563,49559,+15%,"+$42,660",-10.0,-16.0,-17.0,-18.0,BCRX
527,D,2006-05-05 16:26:47,2006-05-03,BCRX,Bennett J Claude,Pres,P - Purchase,$6.50,35000,42996,+438%,"+$227,500",8.0,-9.0,-14.0,-24.0,BCRX
528,D,2006-05-05 16:26:47,2006-05-03,BCRX,Bennett J Claude,Pres,S - Sale+OE,$15.13,-26243,42996,-38%,"-$397,134",8.0,-9.0,-14.0,-24.0,BCRX
529,,2006-05-05 16:18:30,2006-05-03,BCRX,Seidenberg Beth C,Dir,P - Purchase,$15.34,3000,3000,New,"+$46,030",8.0,-9.0,-14.0,-24.0,BCRX
530,D,2006-04-05 14:53:51,2006-04-03,BCRX,Bennett J Claude,Pres,M - OptEx,$16.38,10684,34239,+45%,"+$174,951",-5.0,-5.0,-16.0,-38.0,BCRX
531,D,2006-04-05 14:53:51,2006-04-03,BCRX,Bennett J Claude,Pres,S - Sale+OE,$18.02,-10000,34239,-23%,"-$180,249",-5.0,-5.0,-16.0,-38.0,BCRX
532,D,2006-03-17 13:03:58,2006-03-15,BCRX,Darwin Michael A,CFO,G - Gift,$21.00,-668,0,-100%,"-$14,028",1.0,-3.0,-12.0,-49.0,BCRX
533,D,2006-03-17 13:03:58,2006-03-15,BCRX,Darwin Michael A,CFO,M - OptEx,$2.91,22650,0,-100%,"+$65,890",1.0,-3.0,-12.0,-49.0,BCRX
534,D,2006-03-17 13:03:58,2006-03-15,BCRX,Darwin Michael A,CFO,S - Sale+OE,$19.21,-22650,0,-100%,"-$435,176",1.0,-3.0,-12.0,-49.0,BCRX
535,D,2006-03-07 17:38:38,2006-03-03,BCRX,Bugg Charles E,COB,M - OptEx,$13.20,54882,135577,+68%,"+$724,244",0.0,1.0,-8.0,-45.0,BCRX
536,D,2006-03-07 17:38:38,2006-03-03,BCRX,Bugg Charles E,COB,S - Sale+OE,$20.64,-50000,135577,-27%,"-$1,032,241",0.0,1.0,-8.0,-45.0,BCRX
537,D,2006-03-07 10:58:49,2006-03-03,BCRX,Bennett J Claude,Pres,M - OptEx,$16.38,11550,33555,+52%,"+$189,131",-5.0,-4.0,-14.0,-51.0,BCRX
538,D,2006-03-07 10:58:49,2006-03-03,BCRX,Bennett J Claude,Pres,S - Sale+OE,$21.00,-10000,33555,-23%,"-$209,973",-5.0,-4.0,-14.0,-51.0,BCRX
539,,2006-03-06 13:26:00,2006-03-03,BCRX,Riggs Randall B,SVP Business Development,S - Sale,$20.38,-1512,0,-100%,"-$30,819",-8.0,-4.0,-16.0,-51.0,BCRX
540,,2006-02-14 16:18:56,2006-02-10,BCRX,Featheringill William W,Dir,S - Sale,$16.49,-16200,2782572,-1%,"-$267,099",0.0,15.0,12.0,-50.0,BCRX
541,D,2006-02-14 16:10:45,2006-02-13,BCRX,Bennett J Claude,Pres,M - OptEx,$6.46,6167,32005,+24%,"+$39,870",0.0,15.0,12.0,-50.0,BCRX
542,D,2006-02-14 16:10:45,2006-02-13,BCRX,Bennett J Claude,Pres,S - Sale+OE,$16.94,-3000,32005,-9%,"-$50,826",0.0,15.0,12.0,-50.0,BCRX
543,D,2006-02-02 16:24:14,2006-01-31,BCRX,Riggs Randall B,SVP Business Development,M - OptEx,$6.04,1512,1512,New,"+$9,125",2.0,-13.0,8.0,-43.0,BCRX
544,,2005-12-06 17:55:20,2005-12-02,BCRX,Gordon Carl L,Dir,S - Sale,$14.68,-566667,1100000,-34%,"-$8,318,672",-2.0,2.0,22.0,-12.0,BCRX
545,D,2005-09-27 18:33:31,2005-09-26,BCRX,Bugg Charles E,"CEO, COB",M - OptEx,$8.88,100000,130695,+326%,"+$887,500",-2.0,0.0,57.0,84.0,BCRX
546,D,2005-09-27 18:33:31,2005-09-26,BCRX,Bugg Charles E,"CEO, COB",S - Sale+OE,$10.00,-95000,130695,-42%,"-$950,321",-2.0,0.0,57.0,84.0,BCRX
547,A,2005-07-20 15:00:12,2005-07-13,BCRX,Bennett J Claude,Pres,M - OptEx,$3.59,3800,23269,+20%,"+$13,642",4.0,7.0,16.0,248.0,BCRX
548,D,2005-07-13 17:17:42,2005-07-13,BCRX,Bennett J Claude,Pres,M - OptEx,$2.05,9369,28838,+48%,"+$19,181",7.0,14.0,27.0,268.0,BCRX
549,A,2005-03-03 13:49:31,2003-03-11,BCRX,Sherrill Joseph H Jr,Dir,P - Purchase,$1.06,2700,451900,+1%,"+$2,862",1.0,-9.0,-24.0,52.0,BCRX
550,A,2005-03-03 13:02:28,2003-03-11,BCRX,Sherrill Joseph H Jr,Dir,P - Purchase,$1.06,2700,451900,+1%,"+$2,862",1.0,-9.0,-24.0,52.0,BCRX
551,D,2005-02-09 13:11:26,2005-02-07,BCRX,Bennett J Claude,Pres,M - OptEx,$1.60,2718,19469,+16%,"+$4,348",-3.0,-6.0,-16.0,10.0,BCRX
552,D,2004-05-14 16:45:56,2004-05-12,BCRX,Spencer William M III,Dir,M - OptEx,$4.63,25000,543109,+5%,"+$115,625",-3.0,-7.0,-18.0,-32.0,BCRX
553,D,2004-04-29 14:57:10,2004-04-27,BCRX,Bugg Charles E,CEO,A - Grant,$4.63,100000,125695,+389%,"+$462,500",-4.0,-6.0,9.0,-49.0,BCRX
554,D,2004-04-29 14:57:10,2004-04-27,BCRX,Bugg Charles E,CEO,S - Sale+OE,$9.51,-85000,125695,-40%,"-$808,407",-4.0,-6.0,9.0,-49.0,BCRX
555,D,2004-03-16 12:49:32,2004-03-12,BCRX,Darwin Michael A,CFO,M - OptEx,$0.88,5650,2996,-213%,"+$4,949",-1.0,-3.0,2.0,-30.0,BCRX
556,D,2004-03-16 12:49:32,2004-03-12,BCRX,Darwin Michael A,CFO,S - Sale+OE,$8.06,-5650,2996,-65%,"-$45,533",-1.0,-3.0,2.0,-30.0,BCRX
557,,2004-02-02 15:32:47,2004-01-30,BCRX,Darwin Michael A,CFO,M - OptEx,$3.39,668,668,New,"+$2,266",-1.0,1.0,1.0,-25.0,BCRX
558,A,2004-01-07 15:36:09,2003-09-12,BCRX,Bugg Charles E,CEO,G - Gift,$0.00,-6478,110695,-6%,-$0,0.0,8.0,5.0,-5.0,BCRX
559,A,2004-01-07 15:36:09,2003-10-24,BCRX,Bugg Charles E,CEO,M - OptEx,$6.00,10000,110695,+10%,"+$60,000",0.0,8.0,5.0,-5.0,BCRX
560,M,2003-11-14 16:50:52,2003-11-13,BCRX,Horovitz Zola P,Dir,S - Sale,$8.30,-22000,3000,-88%,"-$182,535",-1.0,-3.0,-21.0,13.0,BCRX
561,,2003-11-07 15:35:26,2003-11-06,BCRX,Horovitz Zola P,Dir,M - OptEx,$4.63,25000,25000,New,"+$115,625",0.0,-7.0,-14.0,-2.0,BCRX
562,,2003-11-05 11:47:58,2003-11-04,BCRX,Montgomery John A,Dir,M - OptEx,$6.00,40000,56585,+241%,"+$240,000",2.0,-2.0,0.0,12.0,BCRX
563,,2003-11-05 11:47:58,2003-11-04,BCRX,Montgomery John A,Dir,S - Sale,$8.50,-40000,56585,-41%,"-$340,000",2.0,-2.0,0.0,12.0,BCRX
564,,2003-10-29 17:22:02,2003-10-27,BCRX,Bvf Partners L P/il,"Indirect Beneficial Owner, 10%",S - Sale,$8.00,-746000,1455900,-34%,"-$5,968,000",-1.0,8.0,6.0,23.0,BCRX
565,,2003-10-28 15:55:23,2003-10-24,BCRX,Bugg Charles E,CEO,M - OptEx,$6.00,10000,117173,+9%,"+$60,000",-7.0,-2.0,-5.0,18.0,BCRX
566,M,2003-08-08 15:41:03,2003-08-06,BCRX,Sherrill Joseph H Jr,Dir,P - Purchase,$4.75,7700,492000,+2%,"+$36,609",-7.0,2.0,28.0,50.0,BCRX
567,,2003-08-05 17:26:04,2003-08-04,BCRX,Sherrill Joseph H Jr,Dir,P - Purchase,$4.05,2100,484300,0%,"+$8,497",3.0,-11.0,17.0,45.0,BCRX
568,,2003-08-04 12:34:31,2003-08-01,BCRX,Sherrill Joseph H Jr,Dir,P - Purchase,$3.99,3600,482200,+1%,"+$14,363",12.0,8.0,37.0,71.0,BCRX
